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ABSTRACT 
 
 H. pylori is a human gastric pathogen that colonizes ~ 50% of the world’s 
population. It can cause gastritis, gastric or duodenal ulcers and also gastric cancer. H. 
pylori produces Helicobacter cysteine rich protein HcpE, a secreted protein which may 
play a role in virulence. In this study we show that HcpE is secreted in the culture 
supernatant both as a soluble protein and in association with outer membrane vesicles, 
and may play a role in the modulation of H. pylori inflammatory responses. We identified 
that DsbHP is necessary for HcpE production and secretion in H. pylori, and demonstrated 
DsbHP has DiSulfide Bond (Dsb) forming activity on reduced lysozyme. Furthermore, we 
demonstrated that DsbHP has a DsbA-type of activity when expressed in E. coli, despite 
its similarity with DsbG, and that DsbHP is involved in maintaining redox homeostasis in 
H. pylori.  
 
 
 
 
 
 
 
 
 
 
Key words: Helicobacter pylori. Disulfide bonds. Dsb proteins. Helicobacter Cysteine-
rich proteins. Protein secretion. 
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CHAPTER 1: INTRODUCTION 
1.1 Helicobacter pylori: a human gastric pathogen 
Helicobacter pylori is a gram negative, spiral shaped microaerophillic bacterium 
that chronically infects human gastric mucosa (Kusters et al, 2006). Over 50% of the 
world’s population is infected with H. pylori, with approximately 30% and 80% infection 
rates in industrialized and non-industrialized countries respectively (Carroll et al, 2004). 
H. pylori causes infections in young and old, as well as healthy and immune compromised 
individuals equally. However, infection with H. pylori is thought to be acquired early on 
in childhood with the onset of disease usually occurring in adults (Goodman and Correa, 
1995). Most acute infections remain asymptomatic, although some nausea, halitosis, and 
epigastric discomfort can occur. Long term chronic infections with H. pylori have been 
associated with peptic ulcers, gastric lymphoma, and gastric adenocarcinoma (Montecucco 
and Rappuoli, 2001). Transmission is believed to occur from person-to-person, via the oral-
oral, or oral-fecal route (Goodman and Correa, 1995). H. pylori transmission is most 
prevalent in communities with poor sanitary conditions, overcrowding and unclean water, 
however host genetics, as well as the infecting strain are thought to also play a large role 
(Vakil and Go, 2000; Sinha et al, 2004).    
The bacterium was first discovered in 1982 by Barry Marshall and Robin Warren, 
for which they were awarded the Nobel Prize in 2005. By performing a self-ingestion 
experiment, they were able to establish the link between H. pylori and peptic ulcers, 
disproving the original theory that eating spicy foods was the primary cause (Marshall and 
Warren, 1984).   
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With approximately a million new cases every year, gastric cancer is the fourth 
most prevalent cancer worldwide, and has the second highest mortality of any cancer 
(CDC, 2012). About 65-80% of all gastric cancers are linked to H. pylori infection, and 
patients diagnosed with H. pylori infection are 6 times more likely to develop gastric 
cancers, with approximately 2% of infected patients eventually developing severe disease 
(Parkin et al, 2002). These findings led the World Health Organization to recognize H. 
pylori as a Group-1 carcinogen in 1995. H. pylori infections can persist over the entire life 
span of patients if gone untreated. Treatment usually include antibiotics and proton pump 
inhibitors which are administered simultaneously. They are poorly tolerated due to their 
numerous side effects, which can lead to a high rate of patient non-compliance and 
treatment failures (Vakil and Go, 2000). This has led to the emergence of antibiotic 
resistance in H. pylori (Gisbert and Pajares, 2002). Thus, a search for novel therapeutic 
targets will help us further understand the mechanisms involved in H. pylori disease 
progression, and help prevent chronic infections that lead to the development of gastric 
ulcers and cancers.   
1.2 H. pylori virulence mechanisms  
For successful colonization, H. pylori must be able to overcome the harsh 
environment of the stomach. This is achieved through the expression of various bacterial 
virulence factors that include structural features like bacterial flagella and 
lipopolysaccharide (LPS), the synthesis of urease to protect against the acidity of the 
stomach, and the production and secretion of toxins and other secretory proteins, which 
alter epithelial integrity and induce inflammatory responses. Together, all these factors 
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contribute to successful chronic infections which can ultimately lead to gastric disease 
(Montecucco and Rappuoli, 2001). 
1.2.1 Urease 
The acidic pH of the stomach makes it a very harsh and uninhabitable environment 
that usually prevents growth of most microorganisms. H. pylori has developed a unique 
strategy to combat this acidity, which allows for its survival in an environment to which it 
would otherwise be susceptible. In the genome of H. pylori, a gene cluster of seven genes 
named ureA-G exists which encode the enzyme urease, and all its accessory proteins (Hu 
and Mobley, 1990; Labigne et al, 1991). Urease is an intracellular nickel-
containing metalloenzyme found in the cytosol which converts urea into carbon dioxide 
and ammonia. Urease is composed of two subunits, α and β, and has been shown to form 
a supra-molecular decameric complex of repeating α-β subunits. Each coupled pair of 
subunits has an active site, for a total of 12 active sites (Ge et al, 2013). The ammonia 
generated following hydrolysis of urea plays an essential role in the survival of H. pylori, 
neutralizing the gastric acid within close proximity. For this process to occur, H. pylori 
must be able to uptake urea from the external environment. Urea enters the periplasm via 
a proton-gated urea channel which is encoded by the gene ureI (Montecucco and Rappuoli, 
2001). This channel remains closed and is only opened when H. pylori detects low pH 
within its environment (Weeks et al, 2000). Urease activity is essential for colonization by 
H. pylori, as mutants unable to express urease are unable to colonize the stomachs of 
gnotobiotic piglets and mice (Eaton et al, 1992).   
Urease activity produces ammonia. Ammonia is toxic to cells at high 
concentrations, and thus may be considered a “double-edged” sword for the bacteria. The 
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concentrations of ammonia that H. pylori produces during an in vivo infection are currently 
not known. However, H. pylori may have some strategic way to control the concentration 
of ammonia produced or it would succumb to toxicity and be unable to maintain chronic 
infection (Montecucco and Rappuoli, 2001).  
1.2.2 Flagella 
Once in the stomach, H. pylori needs to localize to the gastric epithelium to 
establish a successful infection. To accomplish this, H. pylori uses 2 to 6 unipolar flagella 
to propel itself through the mucosal lining until it reaches the underlying epithelium 
(Goodwin et al, 1985). H. pylori flagella are composed of two types of flagellins, 
flagellin A (FlaA) and flagellin B (FlaB). FlaA is the most abundant flagellin, and is 
essential for successful colonization as disruption of flaA results in the attenuation of 
motility and the inability of H. pylori to reach the gastric epithelium. Alternatively, 
disruption of flaB has no effect on the motility of the bacterium (Suerbaum et al, 1993). 
The flagella are covered by a sheath, which is a continuation of the outer membrane, 
containing proteins, lipids, and lipopolysaccharide that protects the flagellum from the 
acidic environment of the gastric lumen (Goodwin et al, 1985).     
 The flagellum is a complex multiprotein organelle that consists of the basal body, 
the hook, and the filament (Goodwin et al, 1985; Geis et al, 1989). The basal body spans 
from the cytoplasm to the outer membrane and is a complex assembly of proteins 
responsible for rotation of the flagellum. The hook serves as a joint connecting the basal 
body to the filament (Fraser et al, 1999). Due to the fact most of the flagellar assembly is 
located beyond the cytoplasmic membrane, many of the flagellar proteins must cross the 
membrane to reach their destination. The partially folded flagellin A and B proteins pass 
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through the central pore in the basal body, the hook and the growing filament, until they 
reach the distal end where they polymerize until the process is complete (Macnab, 2003).  
1.2.3 LPS 
Lipopolysaccharide (LPS) is the major component of the outer membrane of Gram-
negative bacteria (Raetz and Whitfield, 2002).  Bacterial LPS plays an important role in 
the structural integrity of the outer membrane as well as protecting the cell from external 
chemical attack. LPS is also an endotoxin, capable of inducing strong immuno-stimulation. 
The LPS of many different Gram negative species share a common structure consisting of 
three conserved regions (Raetz and Whitfield, 2002). Lipid-A is a phosphorylated 
glucosamine disaccharide to which are esterified with fatty acid chains that anchor the LPS 
into the outer membrane.  The lipid-A portion of the LPS is typically the source of the 
toxicity that is associated with Gram-negative bacteria (Moran, 2008). The oligosaccharide 
is bound directly to the lipid-A core, and is comprised of 10-15 sugars. The outermost 
domain of the LPS is the O-polysaccharide. This region consists of oligosaccharide repeat 
units that can vary from one strain to the next. Due to the fact that the O-polysaccharide is 
exposed at the outer-most surface of the bacterial cell, it is usually one of the primary 
targets of the host immune system via antibody recognition (Moran, 2008).    
The structure of H. pylori LPS has been well studied and characterized (Moran, 
2008). Unlike most other Gram negative species, the lipid-A component of H. pylori LPS 
has low immunogenic properties and low lethal toxicity toward host gastric epithelia 
(Muotiala et al, 1992). Several studies have proposed that the phosphorylation and 
acetylation patterns that are unique to H. pylori lipid-A result in under-phosphorylation and 
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under-acylation compared to other enterobacteria, which result in low immunological 
stimulatory properties (Stead et al, 2008).   
Another unique characterisitic feature that H. pylori O-antigen possesses is the 
presence of extended chains of fucosylated N-acetyllactosamine units. These side chains 
have been shown to mimic human type 2 Lewis blood group antigens Lex and Ley in a 
process known as molecular mimicry. A typical H. pylori O-antigen chain consists of a 
poly(N-acetyl--lactosamine) chain which is heavily fucosylated to form an inner Lex 
region with a terminal Lex or Ley (Moran, 2008). The expression of Lex or Ley on the 
surface is very common in H. pylori and occurs in 80-90% of known strains (Marshall et 
al, 1998). Molecular mimicry allows H. pylori to evade the host humoral immune system 
by decorating itself with structures that the host does not recognize as foreign, and thus 
prevents clearance and promotes chronic infection (Moran et al, 2001).   
H. pylori LPS has also been shown to be important in colonization and 
pathogenesis. The Lex antigen has been shown to play an important role in adhesion to 
gastric tissue. Both O-antigen and Lex expression have been shown to be important for in 
vivo colonization, as strains deficient in Lex or expressing truncated LPS colonized mice 
less efficiently (Edwards et al, 2000; Moran et al, 2000).   
1.2.4 Toxins 
H. pylori encodes two main toxins that are implicated in the development of gastro 
duodenal disease; Vacuolating cytotoxin (VacA) and Cytotoxin associated gene A (CagA) 
(Argent et al, 2006). Strains expressing CagA and VacA are classified as type I strains, 
associated with a poor prognosis characterized by peptic ulceration (Covacci et al, 1993). 
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All strains of  H. pylori contain a copy of the vacA gene, but there is a vast genetic diversity 
causing alleles from various strains to be categorized into multiple different families 
(Atherton, 1995). The allele s1/m1 is the most highly studied form of VacA due to the fact 
that it is associated with a high level of vacuolation compared to most other alleles 
(Atherton, 1995). VacA is a high-molecular weight oligomeric multi-functional toxin. 
VacA is known for its ability to produce vacuoles within the gastric epithelial cells, which 
eventually lead to cell death. However, more recently VacA has also been implicated in 
cellular apoptosis by localizing to and disrupting the mitochondria, preventing T-cell 
activation and proliferation, as well as disruption of endosomal and lysosomal activity 
(Kusters et al, 2006).  
CagA is the most studied and characterized H. pylori virulence factor. The 120–
145 kDa protein is encoded within the cytotoxin-associated gene pathogenicity island 
(cagPAI), a 40kb DNA segment that has been acquired via horizontal gene transfer. The 
cagPAI is composed of 27-31 genes (Censini et al, 1996), which encodes a Helicobacter 
specific type IV secretion system. The type IV secretion apparatus forms a syringe-like 
structure that penetrates the membrane of gastric epithelial cells and allows for the direct 
transport of CagA (reviewed in Blaser and Atherton, 2004). Translocation of CagA into 
gastric epithelial cells results in the induction of a phosphorylation cascade by Src kinases 
to phosphorylate CagA. Phosphorylation of CagA results in actin polymerization and 
rearrangement causing cellular elongation, known as the hummingbird phenotype 
(Tummuru et al, 1995; Segal et al, 1997; Segal et al, 1999). CagA can also have diverse 
effects on the gastric mucosa in the absence of phosphorylation. Unphosphorylated CagA 
can induce inflammation due to activation of NF-κB pathways, can disrupt tight junctions, 
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as well as cause cellular differentiation. These changes eventually lead to the secretion of 
cytokines and chemokines such as interleukin 8 (IL-8) (Tummuru et al, 1995).  
1.2.5 Adhesins 
For colonization to be successful, 4 steps must occur: transmission to the host, 
adherence to host cells within a specific niche, avoidance of host defenses, as well as 
nutrient acquisition. Due to the fact that the human gastric mucosa regularly experiences 
cellular turnover and peristalsis, strong adherence to epithelial cells by H. pylori is one of 
the most important steps and is essential to prevent displacement from the stomach (Ilver 
et al, 1998). Adhesins are bacterial proteins that facilitate interactions between a bacterium 
and host cells during initial stages of infection. H. pylori expresses numerous adhesins that 
can vary among strains as well as growth conditions. Blood group antigen-binding adhesin 
BabA, is one of the most studied and well characterized adhesin proteins of H. pylori. BabA 
is a member of the Hop family of outer membrane proteins (Ilver et al, 1998) that mediates 
binding to fucosylated Lewis b (Leb) blood group antigens expressed on human cells 
(Odenbreit, 2005). The presence of BabA expression is highly correlated to strains 
responsible for duodenal ulcers and adenocarcinoma. The absence of BabA from the outer 
membrane of H. pylori results in decreased adhesion and pathogenicity in vivo, suggesting 
a crucial role in colonization and disease progression (Pohl et al, 2009). BabA is also 
thought to aid in the delivery of other H. pylori virulence factors, such as CagA, upon 
binding to Leb on the surface of the gastric epithelia (Pohl et al, 2009).  
Another well characterized adhesin is the sialic acid-binding adhesin (SabA). SabA 
binds to glycosphingolipids that display sialylated Lewis x (Lex) antigens that are up 
regulated during states of inflammation. H. pylori induced gastric inflammation promotes 
9 
 
 
the replacement of non-sialylated Lewis antigens by sialylated Lex and sialylated Lea, 
implicating SabA as a virulence factor involved in long term chronic inflammation 
(Mahdaui et al, 2002). Clinical isolates demonstrate heterogeneity in their ability to bind 
sialylated Lex, and this variability depends on both the host and the changing epithelial 
receptors during inflammation. This adaptation during inflammation demonstrates the 
ability of H. pylori to acclimate to different conditions during infection. (Pohl et al, 2009).   
H. pylori expresses several other adhesins that have been well characterized and 
found important for colonization. AlpA and AlpB are two outer membrane proteins both 
belonging to the Hop family of proteins, which have been shown to be necessary for Lewis 
antigen independent adhesion (Dhar et al, 2003). Without efficient adhesion, H. pylori 
would be unable to inject toxins and other virulence effector proteins into host cells, as 
well as resist constant peristalsis, resulting in an inability to colonize the harsh environment 
of the stomach (Dhar et al, 2003).  
1.3 Protein secretion systems  
1.3.1 Protein secretion in Helicobacter pylori  
The secretion of proteins is required for common bacterial functions such as the 
release of virulence factors into the extracellular matrix. In H. pylori, the secretome has 
been difficult to analyze due to its preferred growth conditions (Kim et al, 2002). H. pylori 
is commonly cultivated in rich media supplemented with serum, and the proteins within 
the serum make it difficult to analyze any of the secreted proteins (Bumann et al, 2002). 
However, growth in serum free culture conditions have been optimized to facilitate the 
study of H. pylori  
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secreted proteins (Bumann et al, 2002).       
 Five major studies have attempted to analyze the secretome of H. pylori. Using 
two-dimensional gel electrophoresis and mass spectrometry, 26 secreted proteins were 
identified using optimized growth conditions (Bumann et al, 2002). Five different secretory 
pathways have been well characterized in Gram-negative bacteria (Figure 1), however only 
the systems that have functional relevance to H. pylori pathogenesis will be described 
below.  
1.3.2 Sec secretion for the transport of proteins across the inner membrane 
The Sec secretion system is responsible for transporting proteins from the bacterial 
cytoplasm to the periplasm for post-translational folding. This system has been best 
characterized in Escherichia coli. The Sec system within E. coli consists of nine proteins 
that are divided into 3 stages of the secretion process (Manting and Driessen, 2000).  The 
first stage is targeting, whereby the proteins to be secreted into the periplasm are targeted 
to the cytoplasmic membrane. This is facilitated though a Sec signal peptide located at the 
N-terminus end of the protein. A chaperone protein SecB recognizes this signal sequence 
that is 20-30 amino acids in length (Economou, 1999) and facilitates its translocation to 
the cytoplasmic membrane. Due to the fact that the Sec secretion system can facilitate the 
transport of a wide array of different proteins and is found in many bacteria, it must remain 
highly conserved. The Sec secretion signal peptides are highly conserved and contain three 
domains. The first domain is a basic N-terminus with a net positive charge. The second is  
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Figure 1: Summary of the main secretion systems found in Gram-negative bacteria. 
The secretion system relevant to this study is the Sec secretion system and the general 
secretory (type II) pathway.  
Panel A: Sec-dependent secretion systems. 
Panel B: Sec-independent secretion systems. 
 
OM: outer membrane, IM: inner membrane. Adapted from Fronzes et al., 2009. 
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a hydrophobic core, and the final domain is a hydrophilic C-terminus with a consensus 
signal and cleavage site. Once the target protein is recognized by SecB, the second stage 
involving the process of translocation is initiated. This second stage requires a cytoplasmic 
membrane protein capable of translocating the targeted protein from the cytoplasm into the 
periplasm. SecA is a peripheral membrane protein which has ATPase activity, and 
functions as a molecular motor to force the unfolded protein through the protein conducting 
channel (PCC). SecA accepts the target protein from SecB, and through the catalysis of 
ATP, forces the protein through the PCC into the periplasm (Manting and Driessen, 2000). 
This PCC is a translocase that is composed of heterodimers of membrane proteins SecY, 
SecE and SecG. In the third and final stage, the translocated protein now within the 
periplasmic space is released from the membrane via cleavage of the signal sequence by 
signal-peptidases. From here, the protein undergoes proper folding with the aid of 
periplasmic folding proteins. Once properly folded, the protein may reside in the periplasm, 
or may be targeted to the outer membrane for final secretion, or may integrate into the 
membrane (Economou, 1999). To date, homologues of proteins involved in Sec secretion 
have been identified in the H. pylori genome (Fitchen et al, 2003) implying that this system 
is intact and fully functional in H. pylori (Atherton et al, 1995).  
1.3.3 Tat-secretion for the transport of proteins across the inner membrane 
Twin-arginine translocation (Tat) systems are conserved transport systems found 
in many different forms of life including bacteria, archaea, and plant plastids. Unlike the 
Sec secretion system, Tat systems use a proton gradient to transport folded proteins 
across the cytoplasmic membrane (Stanley et al, 2000; Saier, 2006). Tat substrates 
possess N-terminal signal sequences that resemble the overall organizational structure of  
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the Sec secretion signal due to the fact that they contain a positively charged N-region, a 
hydrophobic h-region as well as a short polar C-region that containes the cleavage site. The 
Tat signal sequence is recognized by a conserved sequence containing two arginines. In 
bacteria this motif has been described as Z-R-R-x-Φ-Φ, where the Z refers to any polar 
residue and the Φ refers to a hydrophobic residue (Stanley et al, 2000). In E. coli, the Tat 
system is composed of five proteins, TatA, TatB, TatC, TatD and TatE. TatB and TatC 
associate together to form a stable TatBC complex which is responsible for recognizing the 
Tat signal sequence and bringing the protein into close proximity to the Tat pore apparatus 
encoded by TatA. TatD and TatE are involved in Tat secretion, however their functions are 
not yet understood. The Tat secretion system has been shown to be very important in the 
secretion of virulence factors such as phospholipases, proteins involved in pyoverdine-
mediated iron uptake, anaerobic respiration, osmotic stress defense, motility, and biofilm 
formation (Ochsner et al, 2002; Natale et al, 2008). Analysis of all the sequenced H. pylori 
genomes reveals the presence of tatA, tatB, and tatC which are required to form a fully 
functional Tat secretion system. The Tat system is required for H. pylori virulence as TatC 
is required for viability and successful colonization of H. pylori (Benoit and Maier, 2014).  
1.3.4 Protein folding in the periplasm 
Proteins that are translocated into the periplasm via the Sec system and released 
into the periplasmic space by cleavage of their N-terminal signal sequence need to undergo 
proper folding and maturation. The stability of proteins within the periplasm is very 
important to maintain homeostasis as well as their potential secretion via the general 
secretory pathway. A large number of periplasmic enzymes that are able to catalyze the 
folding and turnover of these proteins have been identified and studied extensively in E. 
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coli. A common mechanism by which proteins containing more than one thiol group are 
folded, is the formation of disulfide bonds between 2 cysteine residues. These bonds can 
be vital for the stability of proteins within the periplasm. In E. coli, the formation of 
disulfide bonds in the periplasm is catalyzed by the Dsb protein system, which will be 
discussed in detail in section 1.4. Another way periplasmic proteins can be folded is by the 
isomerization of peptidyl-proline bonds (Economou, 1999). Proteins that contain proline 
residues can undergo catalysis facilitated by the peptidyl-proline isomerases or PPIs 
(Stathopoulos et al, 2000).  
The periplasm also contains factors that assist proteins in folding correctly. This is 
typically mediated by molecular chaperones and is essential for the secretion of 
extracellular proteins which must acquire a properly folded state before transit across the 
outer membrane. Chaperones recognize hydrophobic regions of proteins that are exposed 
to the surface in the unfolded or mis-folded protein and assist in the prevention of protein   
aggregation or proteolysis. Chaperones can also function as shuttles by targeting secreted 
proteins from the inner membrane to their secretion apparatus in the outer membrane and 
facilitate movement across the periplasm (Economou, 1999).  
1.3.5 General secretory pathway for the transport of proteins from the periplasm to 
the extracellular matrix 
The general secretory pathway or type II secretion system (T2SS) of Gram-negative 
bacteria is a secretion system that translocates proteins from the periplasmic space across 
the bacterial outer membrane to the external milieu. The T2SS and all of its components 
have been well studied and characterized (Clanciotto, 2005). T2SS are encoded by a set of 
12-16 general secretory pathway genes that are organized into large operons. A large 
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translocation pore that spans the outer membrane is responsible for translocating the 
properly folded proteins within the periplasm across the OM into the extracellular 
environment (Cao and Saier, 2003). This pore is composed of 12-15 secretin subunits that 
form a large ring structure with a central pore ranging from 50–80 Å in diameter. This pore 
is large enough to accommodate fully folded proteins. The remaining 11-14 conserved 
components are likely involved in anchoring of the pore and regulating its opening and 
closing (Clanciotto, 2005). This process by which proteins are transported across the 
periplasm to the outer membrane pore is still not fully understood. The type II secretion in 
H. pylori has not been well characterized, however, it is thought that the bacterium uses 
this pathway for the general secretion of proteins as no other general secretion systems 
specific to H. pylori have been identified.    
1.3.6 Direct transport from the cytoplasm to the extracellular environment 
In terms of secretion systems involved in the direct transport of proteins from the 
cytoplasm to the extracellular environment, one has been well characterized in H. pylori, 
the type IV secretion system (T4SS). The T4SS is found in both Gram-positive and Gram-
negative bacteria and is homologous to the conjugation machinery. Thus, the T4SS is 
capable of translocating both DNA and proteins that alter various eukaryotic cell processes. 
The T4SS is composed of approximately 12 proteins that form an inner membrane 
complex, a core complex that spans the periplasm, and a central pilus (Cascales and 
Christie, 2003). The central pilus is composed of VirB2 and VirB5 subunits and serves as 
the secretion tube through which translocated proteins or DNA travel. Three ATPases 
located within the cytoplasm provide power to the secretion apparatus and are essential for 
its function. The T4SS facilitates direct secretion of complex proteins and genetic material 
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across both membranes and into the extracellular milieu or directly into the eukaryotic host 
cell cytosol. In H. pylori, a T4SS is encoded within the cag pathogenicity island and has 
been shown to be highly associated with virulent H. pylori strains. The H. pylori T4SS has 
been implicated in the uptake and secretion of genetic material to promote genetic 
exchange, but is most well-known for its involvement in the secretion of the virulence 
factor CagA into gastric epithelial cells following attachment (Backert and Meyer, 2006).  
1.3.7 Outer membrane vesicle (OMV) mediated secretion 
 
Outer membrane vesicles (OMVs) are spherical structures produced by Gram-
negative bacteria that are composed of a bilayer membrane derived from the outer 
membrane of the cell (Beveridge et al, 1999). They were first discovered in E. coli when 
it was observed that LPS was present within the cell-free culture supernatant (Bishop and 
Work, 1965). Analysis of the supernatant via electron microscopy revealed spherical 
structures composed of outer membrane lipids (Work et al, 1966). Soon after this 
discovery, OMVs were being identified within the cell-free supernatants of many other 
bacteria such as Pseudomonas and Neisseria, revealing that this is a wide spread 
phenomena (Rothfield et al, 1969). When OMVs are extruded from the cell they package 
some of the periplasmic contents within them, and these packaged proteins have been 
shown to be biologically active (Kesty and Kuehn, 2004). Thus, it has been proposed that 
OMVs may act as a secretion system to deliver bacterial proteins into the extracellular 
environment to interact with other bacteria or a host (Gankema et al, 1980; McBroom and 
Kuehn, 2007).  
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Two delivery mechanisms by which OMVs can mediate the secretion of bacterial 
components into the extracellular environment have been proposed. The first mechanism 
hypothesizes that after OMV budding the OMV lyses and the contents within are released 
to diffuse and interact with the potential targets. However, little evidence for this 
mechanism exists. The second mechanism describes the ability of OMVs to fuse to the 
membrane of target cells and the bacterial contents enter via internalization or fusion 
(Kadurugamuwa and Beveridge, 1995).   
OMVs have been shown to have important roles in virulence by trafficking toxins and 
other virulence factors to their targets. Enterotoxigenic E. coli (ETEC) produces heat-labile 
enterotoxin that has been found within OMVs in the culture supernatant. Purified ETEC 
OMVs have been shown to specifically bind, enter, and deliver its active toxin into both 
epithelial and adrenal cells (Hortsman et al, 2000). The toxin NarE, which is produced by 
Neisseria meningitidis has also been observed to be associated with OMV secretion 
(Masignani et al, 2003). Related to this study, H. pylori virulence factors such as VacA 
have been identified within OMVs and have been shown to target host cells through the 
OMV intermediate (Fiocca et al, 1999; Ilver et al, 2004; Ayala et al, 2006). Taken together, 
this clearly demonstrates that many virulence factors are associated and secreted outside of 
the cell through OMVs. Due to the fact that VacA has already been identified to be secreted 
through OMVs, other H. pylori virulence factors may be secreted through OMVs as well.  
1.4 Disulfide bond proteins  
Disulfide bond (Dsb) proteins are oxidoreductases that are involved in the 
formation of disulfide bonds (S-S) in the process of protein folding and maturation. In 
Gram-negative bacteria disulfide bond formation occurs in the periplasm. Dsbs have been 
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extensively studied in E. coli, and used as a model system when comparing homologous 
proteins within other organisms. The Dsb protein system in E. coli is composed of several 
proteins localized within the bacterial periplasm and inner membrane (Raina and 
Missiakas, 1997). Each of these proteins contains a pair of catalytic cysteine residues that 
are involved in the formation of mixed disulfides either with the unfolded protein or with 
a partner Dsb protein. Two separate pathways of S-S formation have been described. 
1.4.1 Pathways of disulfide bond formation 
The oxidative pathway of disulfide bond formation involves the proteins DsbA and 
DsbB. DsbA is an oxido-reductase that contains a thioredoxin domain with a catalytic 
CXXC motif which is responsible for the transfer of its disulfide to a protein with 2 reduced 
thiols by the formation of a disulfide-linked complex. To be active, the two cysteines within 
the CXXC motif of DsbA need to be in the oxidized state (Bardwell, 1994). Upon contact 
with a reduced thiol, a transient mixed disulfide forms between the substrate and the first 
cysteine of the CXXC motif, the disulfide bond is transferred onto the folding protein and 
DsbA is released. This enzymatic reaction results in DsbA being reduced, thus, re-
oxidation must occur to be able to repeat another catalytic cycle. DsbB is a transmembrane 
protein responsible for this process, which obtains its oxidation potential via the Electron 
Transport Chain (Collet and Bardwell, 2002) (Figure 2). DsbA and DsbB interact directly 
(Guilhot et al, 1995) and re-oxidation of DsbA involves two pairs of cysteines presented 
by DsbB in the characteristic CXXC motif.  
In the absence of DsbA, impaired motility, as well as increased sensitivity to metal 
ions have been described, demonstrating the importance of this pathway (Hayashi et al, 
2000). For proteins with only two cysteines, only one disulfide bond is possible. However,  
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Figure 2: Dsb pathways of disulfide bond formation in E. coli. The paradigm for 
disulfide bond formation in the periplasm is best characterized in E. coli. The oxidation 
pathway: The oxidative pathway involves the proteins DsbA and DsbB. DsbA reacts with 
free thiol groups of newly translocated proteins to form a disulfide bond between the 
cysteine residues. DsbA then itself becomes reduced as it accepts electrons from the 
translocated protein. To start a new catalytic oxidation cycle, DsbA must be re-oxidized by 
its partner enzyme DsbB. Electrons flow from DsbB to ubiquinones and to terminal 
oxidases of the electron transport chain. The isomerization pathway: When incorrect 
disulfide bonds are formed, rearrangement is needed. This reaction is catalyzed by the 
thiol-disulfide oxidoreductases DsbC and/or DsbG. These isomerases are maintained in a 
reduced state by the membrane protein DsbD, which is a cytoplasmic thioredoxin. DsbD 
is recycled by thioredoxin reductase in a NADPH-dependent manner. Adapted from 
Kadokura et al., 2009. 
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if a protein contains more than two S-S then mis-matched bonds can occur that are not 
present in the native protein. This can be corrected by the isomerization pathway. 
The isomerization pathway is crucial for proteins that contain more than two 
cysteines. As the number of cysteine residues increases in a protein, the possibility that 
incorrect disulfide bonds will form also increases. In E. coli, the isomerization pathway is 
responsible for correcting these misfolded proteins and involves the isomerase DsbC, 
which rearranges improper S-S into their native configurations (Segatori et al, 2004). 
Similar to the oxidative pathway, the catalytic activity of DsbC is sustained by a 
transmembrane protein, DsbD. However, this protein must maintain DsbC in a reduced 
state to preserve activity (Collet and Bardwell, 2002; Messens and Collet, 2006).   
1.4.2 Importance of Dsb proteins in bacterial virulence 
Dsb proteins of many pathogenic bacteria have been shown to be important for their 
virulence. When the genes encoding these proteins become disrupted or impaired, vast 
effects on virulence factor secretion or direct folding or function can be affected. Defects 
in the DsbA-B oxidation pathway have been shown to be important in bacterial adhesion 
through fimbriae or pili. For example, in Salmonella enterica, the DsbA homologue 
SeSrgA is absolutely essential for the production of fimbriae that are required for intestinal 
adhesion. In S. enterica mutants lacking SeSrgA, intestinal colonization within a murine 
infection model is significantly decreased (Miki et al, 2004). In addition, proteins involved 
in the adhesion to host cells through type IV fimbriae have also been shown to be severely 
affected by DsbA mutations as enteropathogenic E. coli (EPEC) require disulfide bond 
formation within the major sub-unit involved in fimbriae production which the cells use to 
attach to human epithelial cells (Donnenberg et al, 1997).  
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Dsb proteins have been shown to affect the secretion of virulence related proteins 
secreted by the general secretory pathway (type II) (Lasica and Jagusztyn-Krynicka, 2007). 
A hallmark of this pathway is that many of the secreted proteins adopt their active 
conformation in the periplasm following the formation of disulfide bonds, which are 
absolutely essential for their final secretion (Rahme et al, 1997). Dsb proteins promote 
maturation of a number of toxins in the periplasm belonging to the AB5 toxin group, 
including cholera toxin in V. cholerae, pertussis toxin of B. pertussis, as well as the heat 
labile enterotoxin of enterotoxigenic E. coli (Yu et al, 1992).  
Motility is essential for the colonization and or virulence of many bacterial species. 
Many bacteria with mutations in either dsbA or dsbB are non-motile due to their inability 
to produce flagella (Dailey and Berg, 1993). This phenotype is best characterized in E. coli. 
DsbA catalyzes the formation of disulfide bonds within the protein FlgI, which is a 
structural protein within the P-ring of the flagellar motor. The improperly folded FlgI 
protein prevents the integration of FlgC, thus making the cell non-motile (Dailey and Berg, 
1993). DsbA has also shown to be important for the type IV pili mediated twitching 
motility of P. aeruginosa (Ha et al, 2003).  Thus, Dsb proteins and the Dsb pathway of 
disulfide bond formation are important for many aspects of bacterial virulence and may 
serve as potential targets for novel therapeutics.  
1.4.3 Dsb proteins in H. pylori 
The mechanisms of action of Dsb proteins have been studied extensively in E. coli. 
However, this paradigm does not hold true for H. pylori as extensive bioinformatics studies 
have been unable to identify a DsbA homologue. Only 3 Dsb family members (DsbB, 
DsbC, DsbI) have been identified and studied (Tomb et al, 1997; Godlewska et al, 2006; 
24 
 
 
Dutton et al, 2008; Heras et al, 2009). DsbI is believed to function similar to DsbB in 
Campylobacter species, but due to the fact that a DsbA homologue is missing in 
Helicobacter species, the process of oxidative folding is thought to occur via different 
mechanisms. Nonetheless, DsbI has been implicated in playing an important role in 
oxidative folding within the periplasm, as it was recently shown  that dsbI mutants display 
reduced colonization of the stomach within a mouse infection model (Godlewska et al, 
2006).  
Recently, there has been controversy surrounding the identification of a fourth Dsb 
protein. The solved structure of the protein encoded by hp0231 (Yoon et al, 2011), which 
for this study will be referred to as DsbHP, reveals homology similar to that of the E. coli 
DsbG protein (Figure 3). Yoon et al proposed that DsbHP had function similar to E. coli 
DsbG by its ability to correct disulfide bonds and act as a reductase to the substrate 
HP0518. However, conflicting evidence demonstrates that DsbHP also demonstrates 
characteristics that resemble E. coli DsbA oxidase activity due to the act that it was capable 
of refolding denatured and reduced insulin (Roszczenko et al, 2012). Thus, more studies 
need to be conducted to elucidate its role in the Dsb pathway.    
1.5 Helicobacter cysteine-rich proteins (Hcps) 
 Although H. pylori has a small genome, encoding approximately 1600 proteins, 
the function of many of these proteins remains unknown. Within the past decade, a family 
of proteins containing a high percentage of cysteine residues have been discovered, named 
Helicobacter cysteine rich proteins (Hcps). This family contains seven members (HcpA-
F) which are specific to Helicobacter species. It is one of the largest protein families  
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Figure 3: H. pylori DsbHP is an E. coli DsbG homologue. Comparison of the monomeric 
structure of H. pylori DsbHP to E. coli DsbG.  
Panel A: Known structure of the H. pylori DsbG homologue.  
Panel B: Known structure of the E. coli DsbG protein. Adapted from Yoon et al., 2011.  
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specific for proteobacteria from the delta/epsilon subgroup (Mittl et al, 2003). First 
identified and named for their high cysteine content (Cao et al, 1998), these proteins are 
highly conserved among all H. pylori strains that have been sequenced to date (Tomb et al, 
1997; Alm et al, 1999). High antibody titers to HcpA, HcpC, and HcpE have been 
demonstrated within patients infected with H. pylori (Mittl et al, 2003) demonstrating that 
they are produced in vivo and that they are recognized by the host immune system. This 
suggests that Hcps may potentially play an important role in the host response as well as 
the interaction between the bacterium and the host. Understanding the function of Hcp 
family members will be important in determining their role in the host response as well as 
their potential role in H. pylori pathogenesis. 
1.5.1 Sel1-Like Repeats (SLR), the structural components of Hcp proteins 
Hcps are solenoid proteins, which are highly modular proteins that consist of 
repeating intra-molecular sequences. Most repeat units consist of 5-40 amino acids that 
fold into 2-4 secondary structural elements (Ogura et al, 2007).  
SLR units have been divided into three groups based on the number of amino acids 
within each repeat unit. Tetratricopeptide repeats (TPR) were identified in the yeast cdc23 
gene product and were designated tetratricopeptides because they have 34 amino acids 
(AA) in each repeat (Sikorski et al, 1990). Another repeat category is the pentatricopeptide 
repeats (PPR) group, which were identified following analysis of the Arabidopsis genome 
(Aubourg et al, 2000; Small and Peeters, 2000), and were designated penta- as each repeat 
contains of 35 AA. The third and final structural motif was identified following a genome 
analysis representing archaea, bacteria and eukaryotes. The study revealed a motif 
consisting of an /-repeat 36-44 AA in length, and was designated Sel1-like repeat (SLR) 
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(Shultz et al, 1998; Ponting et al, 1999), due to the fact that the motif was discovered in 
the C. elegans sel-1 gene (Grant and Greenwald, 1996).  
The three-dimensional architecture of the SLR motif has been solved via 
crystallography (Das et al, 1998). These studies established that each SLR motif consists 
of a pair of anti-parallel -helices which are equivalent in length and separated by a loop 
of amino acids. A single SLR repeat unit consists of the first α-helix (helix A) attached to 
the second α-helix (helix B) followed by the second loop of amino acids connecting helix 
B to helix A of the following repeat unit.  Structurally, PPRs differ from TPRs by a single 
amino acid insertion in loop 2, and SLRs differ from TPRs by the presence of a 4-12 amino 
acid insertion in loop 1 and a deletion of 2 amino acids in loop 2 (Mittl and Schneider-
Brachert, 2007).  
SLRs are abundant across all forms of life and have been identified in over 858 
different proteins (Ponting et al, 1999). SLRs are characteristic to proteins involved in 
forming macromolecular complexes (Mittl and Schneider-Brachert, 2007), and also can 
play a vital role in cellular processes such as mitosis and transcription within eukaryotic 
cells. However, SLRs have also been shown to be important within prokaryotes as bacteria 
commonly utilize SLR proteins for gene regulation and virulence (Das et al, 1998; Oguru 
et al, 2007). Due to the fact that these motifs are found within both eukaryotes and 
prokaryotes, it has been proposed that SLR motifs are a potential link between signal 
transduction pathways from the two branches of life, suggesting that proteins containing 
these motifs are functionally important in host pathogen interactions. The structure of the 
SLR motifs found within Hcp proteins of H. pylori was accomplished through the 
crystallization of HcpB and HcpC (Luthy et al, 2002; Luthy et al 2004). These structural 
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studies conducted on HcpB discovered that the SLR motif within these proteins are unique 
due to the fact that these Hcp proteins contain a repetitive pattern of paired cysteine 
residues in which two cysteine residues are spaced by 7 AA, with 36 AA between adjacent 
pairs. Additionally, these two cysteine residues stabilize the two -helices of each motif 
by cross-linking and forming disulfide bonds which provide an extra form of stability to 
the structure of the protein (Figure 4). Hcp family members are the only known proteins in 
H. pylori to contain these unique SLR motifs, and contain between 4 and 9 SLRs depending 
on the family member (Luthy et al, 2004).  
1.5.2 Helicobacter-cysteine rich protein E (HcpE) 
Helicobacter-cysteine rich protein E (HcpE) is a 355 amino acid protein encoded by the 
open reading frame (ORF) HP0235 of the H. pylori strain 26695. The protein is annotated 
in the H. pylori genome as a hypothetical secreted protein, with no functional designation 
to date. Work by Mittl et al. established that patients infected with H. pylori have high 
antibody titers to HcpE, indicating that it is well expressed in vivo and induces an immune 
response in the host (Mittl et al, 2003). The Creuzenet lab has also demonstrated this by 
analyzing the serum of over 200 patients (Unpublished). HcpE contains a total of 19 
cysteine residues, one within its signal sequence, and the 18 others occurring in the mature 
protein within each of the 9 SLR motifs. With 19 cysteine residues, HcpE has the highest 
cysteine content (5.4%) of all Hcp family members. In the predicted model of HcpE, the 9 
SLRs are believed to come together to form a super helical structure characteristic of the 
Hcp family of proteins (Figure 5).  
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Figure 4: Structural model of a single SLR unit. Structural modeling of a single SLR 
unit done using SwissProt. The diagram illustrates that the two helices are held together in 
a V-shape in the 3D structure of the protein. The cysteines from each helix (highlighted in 
red) are involved in stabilizing the position of the two helices of the SLR via formation of 
a disulfide bond. Figure courtesy of Dr. Carole Creuzenet. 
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Figure 5: Structural model of HcpE.  
Panel A: HcpE contains 19 cysteine residues. Their position along the peptide sequence is 
depicted by a C. One of the cysteine residues is within the predicted 23 AA long signal 
peptide that is cleaved upon secretion of HcpE into the periplasm. The mature portion of 
the protein is predicted to contain 9 SLR repeats (depicted as red and black cylinders). Each 
SLR repeat is made of 2 -helices (labeled a and b for each SLR) containing a pair of 
cysteine residues.  
Panel B: Predicted super-helical structure of HcpE with 9 SLRs super-imposed using 
PyMol software.  
Panel C: Model of the reconstituted full-length HcpE. Modeling and figure courtesy of Dr. 
Creuzenet.  
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The acquisition of an organized array of disulfide bonds within the HcpE protein is 
anticipated to require proteins of the Disulfide bond protein (Dsb) family (Devi et al, 2006). 
The Creuzenet lab recently discovered that the Dsb homologue DsbHP interacts with, and 
is capable of refolding HcpE (Kichler, 2010). A modified affinity blot with purified DsbHP 
demonstrated that HcpE is capable of interacting with the Dsb homologue (Figure 6). A re-
folding assay was also performed in which purified DsbHP was incubated with insoluble 
HcpE, and its ability to solubilize HcpE was detected by anti-HcpE Western blotting. When 
increasing concentrations of DsbHP were added to insoluble HcpE, the amount of soluble 
HcpE detected in the supernatants increased (Figure 7). This demonstrates that HcpE, and 
presumably the other Hcp family members require Dsb proteins to aid in their folding and 
maturation within the periplasm.  
1.5.3 Putative function of Hcp proteins 
Even though Hcp proteins were discovered over a decade ago, very little has been 
elucidated about their function. Recombinant HcpA, B, and C have been the most studied 
family members, but a consensus on their functions has still not been obtained. 
Recombinant HcpA has been shown to alter the morphology of Thp1 monocytes from 
round to star-like morphologies in vitro. The ability of HcpA to initiate change in 
morphological characteristics of Thp1 cells was shown to be equivalent to that of the tumor 
promoter phorbol 12-myristate 13-acetate (PMA). Star-like morphology is attributed to the 
protrusion of needle-like filopodia as seen by scanning electron microscopy (Dumrese et 
al, 2009). A dose dependent increase in adherence of up to 90% of Thp1 cells within cell  
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Figure 6: HcpE and DsbHP interact. 
DsbHP was shown to interact with denatured HcpE when transferred onto a nitrocellulose 
membrane. Membranes were incubated with enriched DsbHP (Panel A), or buffer only 
(Panel B), and subjected to both anti-Flag as well as anti-HcpE Western blots to visualize 
the presence of DsbHP at 700nm and HcpE at 800nm respectively. DsbHP binds to full length 
HcpE as seen in both Panel A. Full length and truncated HcpE are marked by a black arrow; 
DsbHP -Flag is marked by a red asterix; non-specific E. coli proteins reacting with the anti-
HcpE antibody marked by grey arrow. Figure from Kichler (2010).  
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A. Enriched DsbHP 
B. Buffer 
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Figure 7: DsbHP catalyzes the solubilization of insoluble HcpE in vitro. Enriched DsbHP 
was incubated with insoluble HcpE that had been over-expressed and purified from E. coli. 
Anti-HcpE Western blot demonstrates a dose-dependent response of HcpE to DsbHP, 
resulting in increased soluble full length HcpE. HcpE was present as a doublet which is 
through to reflect its cytoplasmic form with its signal peptide (+SP) and its periplasmic 
form without its signal peptide (-SP). Figure from Kichler (2010).  
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culture flasks was also demonstrated with addition of HcpA, which is thought to be a 
consequence of filopodia formation (Dumrese et al, 2009).  
An increase in cellular adherence and onset of morphological changes are signature 
characteristics for cellular differentiation into macrophages. Dumrese et al investigated the 
uptake of fluorescent microspheres by the altered Thp1 cells. Results showed that Thp1 
cells stimulated with HcpA were capable of phagocytosing 30% of the labelled 
microspheres compared to 10% of the control (Dumrese et al, 2009).  
Additionally, splenocyte cultures incubated with HcpA were shown to promote a Th-
1 bias response with respect to cytokine production (Deml et al, 2005). An increase in 
secretion of IL-6, tumor necrosis factor alpha (TNF-α), interferon gamma (IFN-γ) as well 
as IL-12 were observed after addition of HcpA (Deml et al, 2005). These findings suggest 
that HcpA is potentially involved in the differentiation of host immune cells and 
progression of the immune response against H. pylori. However, this functional ability 
would not help clear H. pylori infections, but rather it is thought to promote the persistence 
of the bacterium in the gastric mucosa (Dumrese et al, 2009). 
1.6 Animal models for studying H. pylori colonization 
When H. pylori was first discovered to be the causative agent of ulcers and gastric 
cancers, studies on pathogenesis was limited due to the absence of adequate animal models. 
Over the years, various animal models have been developed to better understand the 
mechanisms of H. pylori infection and persistence (reviewed in Algood and Cover, 2006). 
Non-human primates such as Japanese monkeys have been used to study H. pylori induced 
gastritis due to the fact that their stomachs are anatomically and physiologically similar to 
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humans. Also, because of their long life span they qualify for long term infection studies 
involving endoscopy and biopsies which resemble human infections (Mattapallil et al, 
2000). However, new animal models needed to be developed due to the difficulties in 
handling of these animals.  
Several rodent models have now been developed to study H. pylori such as rat, 
mice and Mongolian gerbil. These models were chosen due to their ease of treatment and 
their relatively economical stature. However, the first studies to implement this model were 
unsuccessful due to the fact that colonization of clinical isolates were poor, and the 
development of gastric cancers were insufficient (Karita et al, 1991; Marchetti et al, 1995). 
This was until Lee et al successfully adapted a clinical isolate called the Sydney strain 
(SS1), which is capable of efficiently colonizing C57BL/6 mice for long periods of 
infection (≤ 8 months). By successive rounds of colonization and re-inoculation into mice, 
they were able to isolate bacteria which were adequate at colonizing various strains of mice 
including C57BL/6 and BALB/c (Lee et al, 1997). Colonization with strain SS1 results in 
inflammation, increased neutrophil recruitment, and expression of Major 
Histocompatibility Complex II (MHC II) class antigens, which makes this model suitable 
for studies of gastritis. However, peptic ulceration and gastric cancers have not been 
observed in this model (Matz-Rensing et al, 2001). Thus, to study H. pylori induced gastric 
carcinomas, a different rodent model had to be developed.  
Mongolian gerbils were first described as an infection model by Yokota et al . They 
observed that during the first 2 months of infection no significant inflammation or 
infiltration of lymphocytes occured. It was later observed by Hirayama et al that if infection 
of Mongolian gerbils with H. pylori was allowed to proceed longer than 6 months, they 
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would begin observe the formation of irregularly thickened gastric walls, erosion of the 
mucosal lining as well as the formation of hemorrhages (Hirayama et al, 1996). These 
pathological observations were soon followed by ulcers as well as gastric metaplasia 
(Matsumoto et al, 1997; Watanabe et al, 1998). Thus, this model is implemented when 
wanting to study the role and pathogenicity of H. pylori in the development of gastric ulcers 
and adenocarcinomas.  
None of these models are a perfect representation of the pathology observed in 
humans. Intestinal metaplasia has never been observed in non-human primates or mice 
models, and Mongolian gerbils develop lymphoid follicular hyperplasia in the sub mucosal 
layer and gastritis cystica profunda, which have never been observed in humans.  However, 
as in humans, gastric inflammation in conjunction with immune activation is ineffective at 
clearing H. pylori (reviewed in Masaaki et al, 2008), which results in severe general 
gastritis, peptic ulcers or gastric metaplasia, depending on which model is utilized. Hence, 
these animal models have been successfully developed to study infections in vivo which 
enable us to observe some of the most common pathological characteristics in humans 
during H. pylori infection, thus demonstrating the clinical relevance to studying H. pylori 
infection in animal models.   
1.7 Hypotheses and objectives 
DsbHP has the ability to bind to and solubilize HcpE. DsbHP has also been shown to be 
capable of refolding both HP0518 and insulin, however, controversy in terms of its activity 
needs to be resolved. High antibody titers to the HcpE protein in patients infected with H. 
pylori have been observed and other Hcp family members have also been established to 
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potentially play a role in immune modulation. Based on these observations and our current 
understanding of both DsbHP and HcpE, the following hypotheses were proposed: 
- DsbHP is a Dsb related protein, which possesses DsbG-like activity.  
- HcpE relies on DsbHP for its maturation and secretion. 
- HcpE contributes to H. pylori mediated inflammatory response 
- HcpE is secreted outside of the cell via outer membrane vesicles. 
To address these hypotheses, the objectives of this thesis were to: 
1) Determine if DsbHP is capable of forming disulfide bonds 
2) Determine the catalytic activity of DsbHP in terms of its ability to perform 
oxidation or reduction of disulfide bonds 
3) Assess the ability of HcpE to evoke a pro-inflammatory response   
4) Determine if HcpE is localized within the outer membrane vesicles 
CHAPTER 2: MATERIALS AND METHODS 
2.1 Bacterial strains, growth conditions, and reagents 
Bacterial strains and plasmids used in these studies are listed in Table 1. H. pylori 
strains NCTC11637 and SS1 were grown in micro-aerobic conditions of 5% O2, 10% CO2, 
and 85% N2 for 48 hours on either Brain Heart Infusion or Brucella agar plates containing 
10% horse serum or on Columbia agar plates containing 10% blood. Plates were 
supplemented with 0.05 μg/ml sodium pyruvate, trimethoprim (5 μg/ml), vancomycin (10 
μg/ml), and amphotericin B (5 μg/ml). Kanamycin was added to the media when selecting 
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for hcpE::kan and dsbHP::kan knockout mutants and chloramphenicol (8 μg/ml) was used 
to select for the dsbHP and hcpE complemented strains. Unless stated otherwise, all E. coli 
strains were grown at 37°C, in LB broth supplemented with chloramphenicol (34 μg/mL), 
or kanamycin (30 μg/ml) for selection of expression plasmids. 
2.2 SDS-PAGE and Western blot analysis 
Bacterial cells or proteins were denatured in sodium dodecyl sulfate (SDS) buffer 
(0.625M Tris pH 6.8, 2% SDS, 2% 2--mercaptoethanol, 10% glycerol, and 0.002% 
bromophenol blue), and then boiled for 5 min at 100°C and separated on 12% SDS 
polyacrylamide gels. Proteins were visualized by either Coomassie blue staining (10% 
acetic acid, 25% ethanol, 0.01% (w/v) Brilliant Blue R-250), silver nitrate staining, or 
Western blotting. Western blotting was completed by transferring proteins to a 
nitrocellulose membrane (BioRad). Transfer occurred for 50-100 minutes at 180 mAmp, 
depending on the thickness of the SDS gel, in cold transfer buffer (25 mM Tris, 192 mM 
glycine, 10% methanol). The membrane was washed in distilled water and then stained 
with Ponceau Red stain [0.1% (w/v) Ponceau S in 1% (v/v) acetic acid] for 5 min, then the 
membrane was washed in distilled water and scanned. The membrane was subsequently 
washed in Tris Buffered Saline (TBS) buffer (50mM Tris-HCl pH 7.5, 150mM NaCl) for 
10 min and then blocked overnight at 4°C in 2.5% skim milk. The membrane was then 
washed twice in TBS-Tween/Triton (0.05% Tween-20, 0.2% Triton-X 100) buffer and 
once in TBS buffer, for 10 min each. The membrane was incubated in primary antibody 
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Table 1: Bacterial strains and plasmids  
Strains and  
plasmids 
Description                      Reference 
 
Strains 
 
H. pylori 
 
NCTC 11637 
 
NCTC 11637 
 
NCTC 11637 
 
NCTC 11637 
 
 
NCTC 11637 
Wild-type strain 
 
dsbHP::kan 
 
hcpE::kan 
 
dsbHP Comp 
 
 
hcpE Comp 
Lab stock (provided 
by Dr. D. E. Taylor) 
This study 
(Made by J. Lester) 
This study 
(Made by A. Oberc) 
This study 
(Made by B. Oickle) 
This study 
(Made by Jeff Lester) 
 
 
Sydney strain (SS1) 
 
Sydney strain (SS1) 
 
Sydney strain (SS1)  
 
Wild-type strain 
 
dsbHP::kan 
 
hcpE::kan 
Lab stock (provided 
by Dr. N. Jones) 
This study 
(Made by J. Lester) 
This study 
(Made by A. Oberc) 
 
 
E. coli 
  
DH5α     supE Δlac U169 (Φ80lacZΔM15)hsdR recA 
endA gyrA hri relA 
(Hanahan, 1983) 
 
BL21(DE3)pLysS 
 
 
F¯ ompT hsdSB(r B ¯ m B ¯ ) gal dcm Δ(srl 
recA)306::Tn10(DE3) pLy 
 
Novagen, USA 
 
Plasmids 
pHel3 Shuttle vector containing kanamycin resistance 
cassette; Kan R 
(Heuermann and Haas, 
1998) 
pUC18 
 
 
 
 
 
 
 
 
Cloning vector; Apr (Yanisch-Perron et al, 
1985) 
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Table 1: 
continued 
 
Expression plasmids 
 
pET30a-dsbHP-
hcpE 
The hp0235 gene (1085 bp) sub-cloned into 
pET30a-dsbHP-Flag vector expressing a C-
terminal Histidine tagged HcpE protein  
 
This study 
(made by J. Lester) 
pET30a-dsbHP-
Flag-His 
The hp0231 gene (856 bp) cloned into pET30a 
expressing a C-terminal Flag and histidine 
tagged DsbHP protein  
 
This study 
(Made by J. Lester) 
pET30a-dsbHP-Flag The hp0231 gene (856 bp) cloned into pET30a 
expressing a C-terminal Flag tagged DsbHP 
protein  
 
Creuzenet lab 
(Made by S. Kichler) 
   
pET30a-dsbA The ECK3852 gene (627 bp) cloned into                                            
pET-30a expressing a C-terminal               
histidine tagged DsbA protein 
 
This study
(Made by J. Lester) 
pET30a-hcpE The hp0235 gene (1085 bp) cloned into 
pET30a expressing a C-terminal histidine 
tagged HcpE protein 
 
Creuzenet lab 
(Made by J. Chahal) 
pET30a-dsbG The ECK0598 gene (747 bp) cloned into                                            
pET-30a expressing a C-terminal               
histidine tagged DsbG protein 
 
This study
(Made by J. Lester) 
pET30a-gmd 
 
 
 
pET30a-wbpB 
The Cj1319 gene (972 bp) cloned into                                            
pET-30a expressing a C-terminal               
histidine tagged GMD protein 
 
The hp0679 gene (870 bp) cloned into                                            
pET-30a expressing a C-terminal               
histidine tagged WbpB protein 
 
Creuzenet lab
(Made by Alexandra 
Merkx-Jaques) 
 
Creuzenet lab
(Made by Alexandra 
Merkx-Jaques) 
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for 1 hr at room temperature then washed twice in TBS-Tween/Triton-X 100 and once in 
TBS at room temperature. The membrane was incubated in the secondary antibody for 30 
minutes at room temperature in the dark and then washed three times as mentioned above. 
Proteins were visualized using the Licor Infrared Imaging System at a wavelength of 700 
or 800 nm. For anti-His, primary antibody (Mandel Scientific) was diluted 1:5000 and the 
secondary antibody (Mandel Scientific) was diluted 1:3000. For anti-HcpE, primary 
antibody (polyclonal) was diluted 1:5000, and the secondary (Mandel Scientific) was 
diluted 1:3000.  
2.3 Transformation of E. coli competent cells 
To transform plasmid DNA into E. coli cells, 100 µl aliquots of CaCl2-competent 
cells were thawed on ice as previously described (Cohen et al, 1972). Then 1 μL of DNA 
or 15 μL of a ligation mixture was added to the cells and incubated on ice for 30 minutes.  
The cells were then heat shocked at 42◦C for 90 seconds and put back on ice for 1 minute. 
Afterward, 600 μL of LB was added to the cells and the cells were grown at 37◦C while 
shaking for 1 hr and 30 minutes. Then 50 μL of the cell culture was plated on LB agar with 
the appropriate selection antibiotics. For the pET30 constructs kanamycin was used for 
transformation into E. coli DH5 cells and kanamycin + chloramphenicol were used for 
transformation into E. coli BL21(DE3)pLys cells. The plates were incubated overnight at 
37◦C.  
2.4 Cloning DsbHP-Flag-His in a pET30a vector for over-expression 
To allow for easy purification via nickel chromatography, a cleavable C-terminal 
histidine tag was sub-cloned into our pET30a-DsbHP-Flag construct downstream of the 
Flag tag. An inverse PCR was conducted on the pET30a-DsbHP-Flag construct using 
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primers HP0231P3 and HP0231P4 (Table 2). Both primers contained a BamHI cut site to 
be used for ligation purposes with T4 ligase after cleavage by BamHI.  
2.5 Cloning an expression vector containing both DsbHP and HcpE 
To increase the yield of soluble HcpE during expression, we constructed a vector 
that would express both HcpE and DsbHP. The hcpE gene was sub-cloned into our pET30-
DsbHP-Flag construct by PCR amplification of hcpE-His from our pET30a-HcpE-His 
vector with primers T7ProX and CtermHis (Table 2) which contain XbaI and BamHI sites 
used for insertion into the vector. As NheI and XbaI sticky ends are compatible, the 
pET30a-DsbHP-Flag construct was cut with NheI and BamHI and ligated together with the 
HcpE-His PCR product that was cut with XbaI and BamHI to generate the pET30a-DsbHP-
Flag-HcpE-His.  
2.6 Construction of vectors expressing E. coli DsbA-Flag-His and DsbG-Flag-His   
To compare the activity of DsbA and DsbG to that of DsbHP, we constructed 
expression vectors containing E. coli dsbA and dsbG genes. The dsbA and dsbG genes were 
PCR amplified from E. coli strain DH5α using primers DsbAEcP1/P2 and DsbGEcP1/P2. 
The PCR products were then cut with NdeI and BamHI and ligated together with our 
pET30a-DsbHP-Flag-His that was cut with the same enzymes to remove dsbHP from the 
construct. This resulted in the vectors pET30a-DsbA-Flag-His and pET30a-DsbG-Flag-
His. 
2.7 Over-expression and purification of proteins via nickel chromatography  
Protein expression was carried out in E. coli BL21(DE3)pLysS (Novagen). The 
cultures were grown overnight with shaking at 37˚C in 3mL of LB. The next morning, 
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cells were sub-cultured by a 1/50 dilution into 1L of fresh LB medium and grown at 37˚C 
until they reached an OD600nm of 0.5. For optimal expression of soluble HcpE, cultures 
were equilibrated to room temperature for 1 hr before induction. All other expression 
strains were induced at 37oC. All proteins were over-expressed from our pET constructs 
via induction with 0.15 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG, BioShop). 
Cells expressing HcpE were grown O/N at room temperature, whereas all other proteins 
were expressed for 3 hours at 37oC.  Cells were harvested by centrifugation at 6,000 g for 
10 minutes at 4˚C and stored at -20˚C until needed. For purification of  over-expressed 
HcpE, cell pellets were re-suspended in 30 mL cold binding buffer (5mM imidazole, 0.1M 
NaCl, 20mM Tris pH 8.3), whereas cells expressing all other recombinant proteins were 
re-suspended in binding buffer (5mM imidazole, 0.1M NaCl, 20mM Tris pH 7.5). To 
prevent proteolysis, 1 mL of a 1M protease inhibitor cocktail (PIC; Invitrogen) was added 
to the re-suspended cells. The cells were lysed by passaging twice through a cell disruptor 
(Constant Systems LTD IS6/40/BA/AA model) at 25,000 psi. The cellular debris and 
insoluble proteins were removed by centrifugation at 12 000 g for 30 minutes at 4˚C, 
followed by the removal of membranes by ultracentrifugation (Beckman) at 100 000 g for 
1 hr at 4˚C.   
For purification, the supernatant was filtered sequentially through 0.8 μm and 
0.45 μm pore size filters (Millipore Millex-HV) and stored on ice until purification. The 
histidine-tagged proteins were purified by nickel chelation chromatography using Fast 
Protein Liquid Chromatography (FPLC) system with a POROS 1.6 mL column (Applied 
Biosciences).  The column was washed initially with 5 column volumes (CV) of water   
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Table 2: List of nucleotide sequences for primers 
Primer name Sequence (5’ to 3’)  
HP0231P1 GGAAGACCATATGATATTAAGAGCGAGTGTG 
HP0231P2 
HP0231P3 
 
HP0231P4 
HP0231P5 
HP0231P6 
HP0231P7 
CGGGATCCTGCTAGCTCACTTGTCGTCGTCGTCCTTGTA 
GCGGGATCCGGACTGAAAATACAAATTCTCCTTGTCGTC
GTCGTCCTTGTA 
CGCGGATCCCACCACCACCACCACCACTG 
CCGGAATTCATG ATATTAAGAGCGAGTGTGTTG 
CCATCGATGAGCTCACTAAACTTAGGGATC 
CCGGTACCGGTGGCGTTAAGAGCTTGAAC 
HP0235P1 CTCGAATTTAGAGCATAAAGAAGAGCGTAAG 
HP0235P2 CTCGAATTCTCAATACCCCCTAAGTTTAGTG 
HP0230P2 TCGCCTTGCAAGTTTAAAACCC 
HP0232P3 CTGACCCATGGATAGGGATGAGCGCGCGTTTAGG 
DsbAEcP1 GGAAGACCATATGAAAAAGATTTGGCTGGCGC 
DsbAEcP2 GCGGGATCCGGACTGAAAATACAAATTCTCCTTGTCGTC
GTCGTCCTTGTAGTCAGAGCCTTTTTTCTCGGACAGATAT
TTCAC 
DsbGEcP1 GGAAGACCATATGTTAAAAAAGATACTTTTACTGGC 
DsbGEcP2 GCGGGATCCGGACTGAAAATACAAATTCTCCTTGTCGTC
GTCGTCCTTGTAGTCAGAGCCTTTATTCCCCATAATGATA
TTAAGC 
Aph3P1 GAAGATCTGATAAACCCAGCGAACCA  
Aph3P2 CCATCGATAGACATCTAAATCTAGGTAC  
CtermHis CGGGATCCTCAGTGGTGGTGGTGGTGG 
T7ProX 
CatHelP1 
CatHelP2 
TAATACGACTCACTATAGGGG 
GCTCTAGACTCAAAACGATGAAATAGGGC 
GAGGATCCCCGGGTACCG 
 
 
* Restriction sites are in bold and underlined 
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before being charged with 30 CV of 0.1M nickel sulphate. After the column was charged, 
the column was washed with 7.5 CV of 0.1M NaCl and 5 CV of water. The column was 
equilibrated with 10 CV binding buffer that was adjusted to pH 8.3 for HcpE and pH 7.5 
for DsbHP and E. coli DsbG and DsbA. After loading the sample, the column was washed 
with 10 CV of 1X binding buffer to remove proteins that were non-specifically bound to 
the column. Bound proteins were eluted with an imidazole gradient from 50mM to 1.0M 
of elution buffer that was adjusted to the same pH as the 1X binding buffer. Elution 
fractions were collected and run on SDS-PAGE gel to determine which fraction contained 
the protein of interest. The fractions that contained the over-expressed pure proteins were 
pooled and dialyzed O/N in dialysis tubing (VWR) with a 12-14 kDa molecular weight cut 
off in 50mM ammonium bicarbonate buffer pH 8.0 to remove all remaining imidazole. 
Following dialysis the purified proteins were concentrated using polyethylene glycol 
(PEG-8000), then stored in 15% glycerol at -20oC.  
2.8 Protein quantification using the Bio-Rad Bradford protein assay 
  To quantify the concentration of purified proteins, bovine serum albumin (BSA; 
BioRad) that was diluted to 1.36 g/l was used to generate a standard curve. The BSA protein 
standard was serially diluted (0-0.40 g/L) in 50mM ammonium bicarbonate buffer pH 8.0 
in a 96-well plate. The pure protein sample was tested at 3 different concentrations. Then 
10 μL of protein or standard was added to the 96-well plate in triplicate. The Protein Assay 
Dye Reagent Concentrate (BioRad) was diluted 1:4 in water, and 200 μL of the reagent 
was added to each well. Samples were read at 595nm on an Eon microplate reader 
(BioTek).  
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2.9 Solubility assay for expression of HcpE 
To assess optimal conditions for soluble HcpE expression, E. coli BL21(DE3)pLys 
containing either pET30a-HcpE-His or pET30-DsbHP-Flag-HcpE-His was inoculated into 
3 mL of LB broth supplemented with kanamycin (30 µg/mL) and chloramphenicol (34 
µg/mL) and grown overnight at 37oC. The cultures were then sub-cultured into 3 mL of 
LB broth supplemented with the same antibiotics as described above. Cultures were grown 
at either 37˚C or were equilibrated for 1 hour at room temperature before being induced 
with 0.15mM IPTG. All cultures were incubated overnight, then the cells were pelleted by 
centrifugation at 6,000 g for 10 minutes. The supernatants were discarded and the cell 
pellets were re-suspended in buffer (50mM Tris pH 8). Fifty µl of glass beads (Sigma, 
diameter < 106 μm) that were washed 3 times in the same buffer were added. Cells were 
lysed by vortexing with glass beads, with a beads /cell suspension ratio of 1/3 (v/v) for 1 
minute with an additional minute of incubation on ice in between repeats. The resulting 
lysate consisted of the total proteins, of which 100 µl was saved for protein analysis. The 
remaining cell lysate was centrifuged at 12,000 g for 15 minutes to pellet the insoluble 
proteins. The supernatant containing the soluble proteins as well as membrane proteins was 
removed and the pellet containing the insoluble protein fraction was re-suspended in buffer 
(50mM Tris pH 8). HcpE expression levels in the total, soluble and insoluble protein 
fractions were analyzed by SDS-PAGE analysis and Western blotting with anti-HcpE 
antibodies that were isolated from rabbits (Kichler, 2010).  
2.10 Construction of the H. pylori dsbHP knockout mutant 
Primers HP0231P5 and HP0231P2 were used to subclone dsbHP from the pET-
dsbHP-Flag construct into a pUC18 vector. Both the PCR amplicon and pUC18 were cut 
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with BamHI and EcoRI and ligated together using T4 ligase. Inverse PCR was then 
conducted with primers HP0231P6 and HP0231P7 (Table 2), which introduced ClaI and 
KpnI cut sites to allow for gene disruption with a kanamycin cassette. The kanamycin 
resistance cassette was amplified from the vector pHel3 with Aph3P2 and Aph3P4 and 
both products were cut with ClaI and KpnI and ligated together. The resulting plasmid was 
transformed into E. coli DH5α cells using both ampicillin and kanamycin for selection. To 
generate the H. pylori knockout mutants, the constructs were transformed into H. pylori 
NCTC11637 or SS1 using natural transformation (Ge and Taylor, 1997). H. pylori 
NCTC11637 or SS1 were grown on agar plates as described above. Cells were harvested 
and diluted to an OD600nm of 0.2 in a final volume of 100µl. Then, 15-20 ng of plasmid 
DNA was added to the cells, and the entire suspension was plated onto Columbia agar 
supplemented with blood and allowed to recover for 8 hours in micro-aerobic conditions 
at 37oC. Recovered cells were then transferred to Columbia agar containing 4 μg/ml 
kanamycin to allow for selection.  
2.11 PCR screening of the dsbHP::kan knockout mutagenesis clones 
Transformants were analyzed for proper gene integration by PCR using genomic 
DNA isolated with phenol/chloroform extraction. A small pellet of bacteria isolated from 
agar was re-suspended in 500 µl of Cetyltrimethyl ammonium bromide (CTAB) buffer to 
lyse the cells. An additional 500 µl of phenol/chloroform/isoamyl alcohol (25:24:1, pH 
8.0) was added to the suspension and vortexed for 30 seconds and then centrifuged for 5 
minutes at 13,000 g. The supernatant was removed and put into a fresh Eppendorf tube 
where 500 µl of chloroform/isoamyl (24:1) was added. Vortexing and centrifugation were 
repeated as described above. The supernatant was removed and 48% (v/v) isopropanol and 
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10% (w/v) 3M sodium acetate was added and the suspension was kept on ice for 30 minutes 
to precipitate the chromosomal DNA. To pellet the DNA, the suspension was centrifuged 
at 13,000 g for 15 minutes. Then, 1 mL of ethanol was added to remove any salts and 
centrifugation was repeated. The ethanol was removed and the DNA was kept at 37oC for 
10 minutes to evaporate any leftover ethanol. The DNA pellet was then re-suspended in 50 
µl of distilled water and the chromosomal DNA was used in PCR screening reactions. The 
primer pairs used were HP0231P1/P2 and HP0230 P2/HP0232 P3 (Table 2).  
2.12 Analyzing H. pylori for detection of HcpE 
 Wild-type, dsbHP::kan, and hcpE::kan H. pylori strains were grown on Columbia 
Agar medium with background and selective antibiotics for 48 hrs. After 48 hours, the cells 
were sub-cultured into 100 mL of Brucella broth at an OD600nm that was adjusted to 0.2. 
The Brucella broth was supplemented with 1% β-cyclodextrin and the required antibiotics. 
Cell suspensions were grown at 37oC with gentle shaking under micro-aerobic conditions 
using sealed anaerobic jars and gas packs (CampyGen; Oxoid) for 16 hours.  The cell 
suspensions were pelleted via centrifugation at 4000 g for 30 minutes at 4˚C. Aliquots of 
each total culture, as well as culture supernatant and OMVs were set aside for 
quantification of cell lysis. OMVs were obtained via ultra-centrifugation of culture 
supernatants at 150,000 g for 3 hrs, and resuspended in 200 µl of Tris-HCl pH 8.0. The 
total cell pellets were re-suspended in 500 μL of 1X SDS-PAGE protein loading buffer, 
whereas the ultra-centrifuged supernatants were then concentrated 10 fold by 
centrifugation with a centricon with a 10 kDA cut off (Millipore), and 50 µl of 1X SDS-
PAGE protein loading buffer was added.  The total cells, concentrated supernatants, and 
OMVs were analyzed by SDS-PAGE (12%) and HcpE was detected by Western blotting 
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with the anti-HcpE primary antibody diluted 1:5000, and goat anti-rabbit IgG secondary 
antibody detected at 800nm.  
2.13 OMV preparation and analysis 
The bacteria were inoculated into cyclodextrin-containing broth as described 
above. The supernatants were collected after 16 hour incubation by centrifugation of the 
culture at 2,057 g for 10 minutes, followed by filter-sterilization (0.45 µm size). The filter-
sterilized supernatant was then ultra-centrifuged at 150,000 g for 3 h at 4 oC to pellet the 
OMVs. The OMVs were re-suspended in phosphate buffered saline (PBS, 9 mM NaPO4, 
27 mM NaCl, pH 7.4).  
2.14 Urease activity assay to assess cellular lysis of H. pylori cultures 
To compare the urease activity of the total cells, cell supernatants, and OMVs, 
aliquots obtained from H. pylori Brucella broth cultures were recovered. Then, 20 μL of 
each sample, repeated in triplicate, was added to 200 μL of urease reagent (50mM sodium 
phosphate pH 7.5, 0.15M NaCl, 1M Urea, 0.001% phenol red). Urease activity was 
assessed by monitoring OD565nm over 2 hours in a 96-well plate using an Eon microplate 
Reader (BioTek). The colour change of the phenol red reagent from yellow to pink reflects 
the change of pH occurring upon the conversion of urea to ammonia and carbon dioxide 
by urease in a slightly buffered solution.  
2.15 Cell fractionation of H. pylori  
H. pylori cells were grown in cyclodextrin-supplemented Brucella broth for 16 
hours (Marchini et al 1995). The cell pellet from 100 ml of culture was washed 3 times 
with PBS and re-suspended in 3 mL of ice cold 0.5 mM MgCl2 and 30% (w/v) sucrose to 
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form spheroplasts. Spheroplast formation was checked by phase contrast microscopy 
(Leitz Laborlux K) every 20 minutes while cells were maintained on ice. The spheroplasts 
were pelleted by centrifugation at 4,000 g for 10 minutes at 4oC. The supernatant 
containing periplasmic proteins was reserved on ice. The spheroplasts were lysed by re-
suspension in 1 mL of water, addition of acid-washed (and neutralized) glass beads (Sigma, 
diameter < 106 μm), with a beads /cell suspension ratio of 1/3 (v/v) with 4 cycles of 
vortexing for 30 seconds and cooling on ice for 30 seconds. The cytoplasmic protein 
fraction was obtained by centrifugation at 12,000 g for 30 minutes at 4°C followed by 
ultracentrifugation (Beckman) at 100,000 g for 1 h. The membranes recovered in the 
ultracentrifugation pellet were further separated into inner and outer membrane fractions 
by differential solubilization with lauryl sarcosyl (Filip et al, 1973). The pellet was re-
suspended in 500 µl of 50 mM Tris-HCl pH 7.5 containing 1% (w/v) N-lauroyl-sarcosine 
sodium salt (Sigma) and incubated at room temperature for 1 h. The inner membranes were 
recovered in the supernatant following ultracentrifugation at 100,000 g for 1 h at 4ºC. The 
outer membrane proteins recovered were re-suspended in 500 µl of 50 mM Tris-HCl pH 
7.5. Then 20 µl of all fractions were analyzed by SDS-PAGE (12%), with Coomassie blue 
staining and Western blotting with anti-HcpE antibodies.  
2.16 Electron microscopy of outer membrane vesicles    
Electron microscopy images were obtained by Ryan Chanyi at the Electron 
Microscopy unit in the Molecular and Cellular Imaging Facility at the University of 
Guelph. The OMV samples were negatively stained with 2% uranyl acetate and visualized 
using an FEI Tecnai G2 F20 field emission electron microscope operating at 120 kV. 
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Images were obtained using a bottom mount Gatan 4k CCD camera using Tecnai Imaging 
and Analysis software.  
2.17 Lysozyme refolding assay  
This assay was performed following previously reported methods in the literature 
(Puig and Gilbert, 1994; Puig et al, 1997). Lysozyme was denatured and reduced with 
denaturing buffer (8M urea, 130 mM β-mercaptoethanol, 25 mM Tris-HCl pH 8.6) for 
1hour at 37oC to a final concentration of 0.7 mM to 6.7 mM.  The sample was then 
diluted 35 fold in 0.1 M acetic acid to a final concentration of 20-200 μM of lysozyme. 
Refolding reactions were set up by first diluting the sample further to 1.0 to 10 μM of 
lysozyme in refolding buffer (5 mM reduced glutathione GSH, 0.5 mM oxidized 
glutathione GSSG, 100 mM HEPES, pH 7.0, 20 mM NaCl, 2 mM EDTA, 5 mM MgCl2), 
then adding  5 μM of purified DsbHP-Flag-His, DsbA-Flag-His or DsbG-Flag-His to the 
reaction. Refolding was performed in 100 μl reactions and was left to proceed for 1h at 
37oC. The reactions were then quenched by addition of an equal volume of 0.1 M acetic 
acid. 
    Lysozyme refolding was then assessed by measuring the ability of lysozyme to 
lyse Micrococcus lysodeikticus (Sigma) as described previously (120). Refolded 
lysozyme at a final concentration of 1.0 and 1.5 μM was added to a 0.5 g/l cell 
suspension of Micrococcus lysodeikticus (BioShop) in reaction buffer (60 mM potassium 
phosphate, 0.1% NaCl, pH 6.2). The decrease in turbidity was monitored 
spectrophotometrically at OD650nm for a duration of 1 hour at 25
oC. The assays were 
performed in triplicate in 96-well plates using an Eon (Bioteck) plate reader. Control 
reactions were done using the same molarities of native lysozyme that was diluted in the 
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same solutions (0.1 M acetic acid, refolding buffer and lysis reaction buffer) as well as no 
lysozyme.  
2.18 Dithiothreitol exposure assays in E. coli  
E. coli BL21(DE3)pLys containing expression vectors for either DsbHP-Flag-His, 
DsbA-Flag-His, DsbG-Flag-His and GmD-His were grown O/N at 37oC  in 3 mL of LB 
broth supplemented with kanamycin (30 µg/mL) and chloramphenicol (34 µg/mL). The 
following morning all cultures were sub-cultured (1/50 dilution) into 10 mL of LB broth 
with the same antibiotics and then induced with 0.1 mM IPTG when the OD600nm reached 
0.5. Protein expression was allowed to proceed for 3 h at 37oC. Cultures not induced were 
grown in parallel to be used as controls. Cultures were then serial diluted on to LB agar 
containing either 0, 5, 7.5 or 10 mM dithiothreitol (DTT) in duplicate. The plates also 
contained kanamycin at 30 μg/ml and chloramphenicol at 34 μg/ml to maintain the 
expression of the pET30a- DsbHP-Flag-His, DsbA-Flag-His, DsbG-Flag-His and GmD-His 
plasmids. Growth was assessed after overnight incubation at 37oC. Protein expression was 
assessed by anti-His Western blotting on the pre-induced cultures before spot plating as 
well as on cells that were recovered from the agar plates after overnight growth.  
2.19 Dithiothreitol exposure in liquid broth  
Similarily to the assay described above, E. coli cultures were grown and pre-
induced in the same manner except they were inoculated into LB broth at a 1/4000 dilution 
(100 μl total) in the wells of a Bioscreen plate instead of spotted onto LB agar. E. coli was 
grown in the presence of 0, 7.5 or 10 mM DTT supplemented with 0.1 mM IPTG or not 
and growth was monitored automatically over 24 hours at 37oC under agitation. Protein 
expression was assessed similarly as in the plate spotting assay by anti-His Western 
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blotting on the pre-induced cultures before and after inoculation. Then 10 µl of each E. coli 
strain was withdrawn from the bioscreen plate at 6 hours and 24 hours post inoculation. 
2.20 H. pylori exposure to dithiothreitol and hydrogen peroxide  
H. pylori NCTC11637 wild-type, dsbHP and hcpE mutants were grown on  
Columbia agar containing background antibiotics and appropriate selection antibiotics 
(refer to section 2.1). After 48 hours of incubation, the cells were sub-cultured onto a full 
plate. After another 48 hours of incubation, the cells were harvested and re-suspended into 
Brucella broth and cell densities were normalized according to OD600nm.  
For the dithiothreitol assay, the cell density was adjusted to 0.5. A 10 fold serial 
dilution was made (100-10-5) and cells were spot plated (10 µl) onto agar containing 0, 8, 
10 or 12 mM dithiothreitol.  
For the hydrogen peroxide assay, the OD600nm was adjusted to 1 in a total volume 
of 100 µl of Brucella broth within a 96-well plate containing 75, 100 or 125 mM H2O2. 
After 30 min incubation in micro-aerobic conditions, a 10 fold serial dilution was made 
(100-10-5) and cells were spotted on Columbia blood agar.  
2.21 LPS extraction and analysis 
LPS was extracted from the wild-type, dsbHP and hcpE knockout mutants 
(Hitchcock and Brown, 1983). Cell pellets from each strain were washed in 0.85% saline 
and re-suspended in 200 μL lysis buffer (2% SDS, 4% -mercaptoethanol, 10% glycerol, 
1M Tris pH 6.8, and bromophenol blue). The samples were boiled for 30 minutes at 100°C. 
Proteinase K (BioShop) was added to a final concentration of 0.5 μg/mL and incubated for 
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1 hour at 60°C to digest protein within the sample. The LPS was analyzed by SDS-PAGE 
(12%) and stained with silver nitrate.   
2.22 Silver nitrate staining of LPS samples 
LPS preparations of wild-type, dsbHP and hcpE knockout mutants were stained 
using the modified Ultra-Fast silver staining protocol (Tsai and Frasch, 1982; Fomsgaard 
et al, 1990). Following SDS-PAGE gel electrophoresis, LPS within the gel was oxidized 
with oxidizing buffer (0.7% periodic acid, 40% ethanol, 5% acetic acid) for 20 minutes, at 
room temperature. The oxidizing solution was removed using a vacuum filter and the gel 
was washed 5 times in distilled water for 3 minutes. The gel was stained for ten minutes 
with staining solution (20% (w/v) AgNO3, 0.002% (v/v) NaOH, 0.4% (v/v) NH4OH). The 
stain was removed and the gel was washed again 5 times with distilled water for 3 minutes. 
The gel was developed via reduction in water containing 0.00005% (w/v) citric acid and 
0.00054% (v/v) formaldehyde. After colouration was resolved enough, the reaction was 
stopped via addition of 10% acetic acid for 1 min followed by thorough washing with 
distilled water.  
2.23 Separation of inner and outer membranes 
H. pylori cell pellets were re-suspended in 0.85% saline and lysed via vortexing 
with glass beads (refer to section 2.9). Membranes were isolated from the lysate by 
ultracentrifugation (Beckman) at 100 000g for 1 hour at 4oC. After centrifugation the 
supernatant was removed and stored at -20 ºC. The inner membrane proteins were then 
separated from outer membrane proteins by sodium lauroyl-sarcosine treatment of the total 
membrane preperation. The pellet was re-suspended in 50mM Tris-HCl pH 7.5 containing 
1% (w/v) N-lauroyl-sarcosine sodium salt (Sigma) and incubated at room temperature for 
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1 hour with gentle shaking. After ultracentrifugation at 100 000 g for 1 hour at 4ºC, the 
supernatant containing the soluble inner membrane proteins and peptidoglycan was 
removed and the pellet containing the outer membrane was re-suspended in 50mM Tris-
HCl pH 7.5. All fractions were visualized following separation by SDS-PAGE (12%) and 
staining with Coomassie blue and silver nitrate.   
2.24 Analysis of H. pylori clinical isolates 
H. pylori strains isolated from gastric biopsies from patients diagnosed with various 
H. pylori related gastric diseases such as gastritis, ulceration and atrophy, were obtained 
from Dr. Hristo Atanassov. A total of 13 strains were analyzed for the presence of HcpE 
production. The clinical isolates were grown on Columbia blood agar plates for 48 hours 
in micro-aerobic conditions. After 48 hours, cells were sub-cultured onto 1 entire Columbia 
blood agar plate and grown for 48 hours at micro-aerobic conditions. Cells were then sub-
cultured into Brucella broth supplemented with 1% β-cyclodextrin, sodium pyruvate (0.05 
μg/ml), trimethoprim (5 μg/ml), vancomycin (10 μg/ml), and amphotericin B (5 μg/ml), 
and normalized to OD600nm 0.2 and grown for 16 hours at 37
oC. Liquid cultures were 
collected and the culture was centrifuged at 2,057 g for 10 minutes. The culture supernatant 
was removed and the cell pellets were stored at -20oC until needed. The supernatant was 
then filter-sterilized (0.45 µm size). The cell pellets (total cells) and the culture supernatant 
were analyzed via SDS-PAGE electrophoresis and anti-HcpE Western blot. 
2.25 Murine infection model and analysis with H. pylori 
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2.25.1 H. pylori colonization in C57BL/6 mice 
All experiments were done according to approved protocol AUP 2012-10. H. pylori 
wild-type, dsbHP and hcpE knockout mutants were grown on Columbia blood agar plates 
for 48 hours in micro-aerobic conditions. After 48 hours, cells were sub-cultured onto 3 
Columbia blood agar plates and grown for 48 hours at micro-aerobic conditions. Cells were 
then resuspended in Brucella broth and normalized to OD600nm 2 which was equivalent to 
1.0x109 cells per 100 µl. C57BL/6 mice (Charles River) were then orally gavaged with 100 
µl of either wild-type, dsbHP or hcpE mutant until a total of 12 mice had been gavaged with 
each strain. To establish infection, mice were orally gavaged every other day within a week 
totaling 3 oral gavages. During the first oral gavage, 50-100 µl of blood was also collected 
from the tail vein for anti-HcpE ELISA. Infection was allowed to proceed for 4 weeks post 
gavage until the first 6 mice from each group were sacrificed. Mice were sacrificed by 
peritoneal injection with 100 µl of pentobarbital (Ceva). Up to 500 µl of blood was taken 
by intracardial collection and the stomach as well as the spleens were harvested to analyze 
colonization, inflammation, and immune activation. The stomachs were separated into 2 
halves, and 1 half was sent for histological analysis and the other half was used for 
homogenization to assess colonization. The other half of the mice were sacrificed 6 weeks 
post gavage and the blood and organs harvested as described above. Mice that were 
gavaged with Brucella broth only were used as controls. 
2.25.2 Homogenization of stomach tissue to assess colonization 
To assess colonization, half of the murine stomachs that were harvested from mice 
gavaged with either wild-type, dsbHP mutant, hcpE mutant or Brucella alone were 
homogenized and plated onto blood agar plates. Briefly, after being harvested and divided 
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into 2 halves, the murine stomach tissue was washed 3 times in 1X PBS supplemented with 
amphotericin B (5 µg/mL), vancomycin (10 µg/mL), trimethoprim (5 µg/mL), and 
nalidixic acid (2 µg/mL) to remove stomach contents. After washing, tissue samples were 
placed into 3 mL of the same PBS buffer with antibiotics and homogenized for 1-2 minutes 
with an electric homogenizer (Fisher Scientific). After homogenization, the gastric 
homogenate was diluted 10 and 100 fold, and 100 µl of each dilution was plated onto 
Columbia blood agar containing the same antibiotics as the PBS buffer. Plates were 
incubated in micro-aerobic conditions for 5-7 days. The remaining homogenate was stored 
at -20oC.    
2.25.3 Preparation and analysis of gastric tissue for histology 
Stomach tissue that was harvested from mice gavaged with either wild-type, dsbHP 
mutant, hcpE mutant or Brucella alone was fixed in buffered formalin (VWR) for 72 hours. 
The fixed tissue was washed in PBS once every 8 hours for a total of 5 washes. Tissue was 
then stored in 70% ethanol until dehydration and paraffin wax infusion in an automatic 
tissue processor (Leica ASP200 S) at Robarts Research Institute was performed. Processed 
samples were then embedded into paraffin wax, and when hardened were cut into 5 µm 
thick sections using a microtome. Sections were processed in duplicate: half were sent to 
the pathology department in University Hospital for Warthin-Starry staining for H. pylori 
detection and visualization and the other half were stained with hematoxylin and eosin stain 
(H&E) to visualize and assess inflammation.   
2.25.4 Isolation and preparation of splenocytes 
Murine spleens were harvested from C57BL/6 mice that were infected with either 
wild-type, dsbHP::kan, hcpE::kan mutants, or naïve mice. Splenocytes were isolated by 
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manual homogenization with a glass homogenizer in 5 mL of sterile endotoxin free PBS 
(Corning) that contained trimethoprim (5 µg/mL) and vancomycin (10 µg/mL). The 
homogenization mixture was then centrifuged at 500 g for 7 minutes at room temperature. 
The cell pellet was re-suspended in 4 mL of ammonium-chloride-potassium (ACK) buffer 
(NH4Cl 0.15M, KHCO3 10 mM, EDTA 0.1 mM) to lyse the red blood cells. Then 10 mL 
of 1XPBS was added to dilute the ACK buffer to prevent death of the splenocytes, and 
centrifuged at 500 g for 7 minutes. The supernatant was discarded, and the cellular pellet 
containing splenocytes was washed with 7 mL of 1XPBS and centrifuged again at 500 g 
for 7 minutes. The cell pellet was re-suspended in 10 mL of RPMI (Thermo Scientific) 
supplemented with 10% FBS (Gibco) and 2.5% Hepes (Gibco). Splenocytes were then 
counted using a haemocytometer and Trypan blue to determine total cell counts, as well as 
the number of live and dead cells.  
2.26 Interaction assays with splenocytes 
 Splenocytes isolated as described above were plated into 96-well tissue culture 
plates (VWR) and equilibrated for 2 hours at 37oC in 5% CO2 before cells were infected. 
For each experiment, the concentration of cells per milliliter was calculated by counting 
the cells with a haemacytometer and 0.5-2 x 106 cells were plated in each well. Cells were 
then infected with H. pylori wild-type, dsbHP::kan or hcpE::kan which were grown for 48 
hours on Columbia blood agar with background and selective antibiotics. The cells from 
plates were resuspended in serum-free Brucella broth, supplemented with -cyclodextrin 
for 12 hours, as previously described (refer to section 2.12). The bacterial cultures were 
centrifuged at 2057 g for 30 minutes at room temperature to pellet the cells.  The cell pellet, 
representing the total cells, was re-suspended in complete Roswell Park Memorial Institute 
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(cRPMI) medium such that the splenocytes were infected with H. pylori at a multiplicity 
of infection (MOI) of 1, 0.5, and 0.1 bacteria per splenocyte. H. pylori cell supernatants 
were concentrated via lyophilization and then re-suspended in 1/10 of the original volume 
of cRPMI medium and further diluted to final concentrations of 5, 3, and 1X. Splenocytes 
were also infected with pure HcpE and DdahB that were either treated or not with 
Proteinase K (at concentrations of 75, 125, and 200 mM). The splenocytes were infected 
for 12 or 24 hours. At each time point, the supernatants were recovered and was kept for 
cytokine analysis (stored at -20˚C). 
2.27 Quantification of IFN-γ production by ELISA 
The IFN- γ ELISA was carried out using the READY-SET-GO! Mouse Interferon 
gamma kit (eBioscience) according from the manufacturer’s recommendations. A 96-well 
plate was coated with 100 μL/well of capture antibody (purified anti-mouse IFN-γ) in 
Coating buffer. The coating buffer was diluted 10 fold and 1 µl of antibody was added for 
every 1 mL of coating buffer. The plate was covered and incubated O/N at 4◦C. The next 
morning, the wells were aspirated and washed 3 times with 200 μL Wash Buffer (1X PBS, 
0.05% Tween-20), allowing the buffer to soak for one minute between washes. The plate 
was blotted dry on absorbent paper after the final wash to remove residual buffer. To block 
the plate, Assay Diluent (provided in kit) was diluted 1 in 5 in MilliQ, to make a 1X 
solution, and 100 μL were added to each well and incubated for 1 hour at room temperature. 
After incubation, the plate was aspirated and washed 3 times, as before. To generate a 
standard curve, the standard recombinant mouse IFN-γ (provided in kit) was diluted into 
1X assay diluent. The stock solution, 2000 pg/mL, was prepared by adding 20 μL of the 
standard to 10 mL of assay diluent. The stock was then serially diluted yielding solutions 
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of 1000, 750, 565.2, 421.9, 316.4, 237.3, 178, 133.5, 100, 75, and 0 pg/mL. The standard 
and splenocyte samples were added to the plate, 100 μL/well in triplicate. The plate was 
sealed and incubated at room temperature for 2 hours. The wells were aspirated and washed 
3 times with wash buffer as previously described. Detection antibody diluted in 1X assay 
diluent was added, 100 μL/well, and incubated at room temperature for 1 hour. The 
detection antibody (Biotin-conjugated anti-IFN-γ, polyclonal) was prepared by adding 12 
μL of antibody solution to 12 mL 1X assay diluent. The plate was washed 3 times with 
wash buffer and then the enzyme Avidin-HRP* diluted in 1X assay diluent was added, 100 
μL/well and incubated as room temperature for 30 minutes. The Avidin-HRP enzyme was 
prepared by adding 48 μL of the enzyme solution to 12 mL assay diluent. The plate was 
washed 3 times with wash buffer, then again with 1X PBS to remove traces of Tween. 
After thorough washing and blotting the plate dry, 100 μL of Substrate solution (1X 
tetramethylbenzidine) was added to each well and incubated at room temperature for 15 
minutes, or until sufficient blue colour developed. To end the reaction, 50 μL/well Stop 
solution (1M H2SO4) was added. The plate was read immediately after adding the stop 
solution using the EON plate reader (Biotech) at 450 and 570 nm. To analyze the data, the 
570 nm readings (background) were subtracted from the 450 nm readings. 
CHAPTER 3: RESULTS 
3.1 Molecular tools developed to study DsbHP and HcpE 
 To facilitate the study of DsbHP and its effect on the secretion of HcpE, a number 
of molecular tools had to be developed. This included generating recombinant proteins by 
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over-expression and purification, as well as developing H. pylori dsbHP knockout mutant 
and hcpE complement strains.  
3.1.1 dsbHP::kan knockout mutagenesis 
The Creuzenet lab has previously demonstrated that DsbHP is a potential folding factor 
capable of binding to and refolding insoluble HcpE (Kichler, 2010). Thus, DsbHP may be 
important for the secretion of HcpE into the extracellular matrix. To investigate the role 
that DsbHP plays on the secretion of HcpE, the dsbHP gene was knocked out in the laboratory 
strain, NCTC 11637. The dsbHP mutant was constructed by disrupting the chromosomal 
copy of the dsbHP gene with a kanamycin resistance cassette via homologous 
recombination. The construct was designed as to orientate the kanamycin resistance 
cassette in the same transcriptional orientation as dsbHP to reduce the potential risk of 
polarity caused by altering gene expression (Figure 8A). All potential clones were isolated 
from agar plates containing kanamycin for selection, then screened for the presence of the 
disrupted dsbHP gene containing the kanamycin resistance cassette, as well as correct 
insertion and orientation into the chromosome via PCR. The dsbHP disrupted construct was 
amplified using the primers HP0231P1 and HP0231P2, whereas primers HP0230P3 and 
HP0232P2 (Table 2) were used to determine correct orientation and insertion into the 
chromosome. A PCR amplicon of 1773 bp within the dsbHP mutant indicated that the gene 
was disrupted by the Kan cassette and was successfully integrated in the genome (Figure 
8B). Likewise the presence of a 3228 bp band in the mutant confirmed that the location 
and orientation were correct (Figure 8C).  
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Figure 8: PCR screening of dsbHP knockout mutagenesis clones. For all panels, 
diagrams are not to scale.  
Panel A: Diagram of the dsbHP coding region (hp0231) in wild-type and knockout mutant 
showing all primer locations used in the PCR screening and the expected PCR amplicon 
sizes. 
Panel B: PCR amplification using knockout mutant chromosome with primers HP0231 
P1/P2 indicate that the dsbHP gene was successfully disrupted in all clones tested. 
Amplification of dsbHP from wild-type chromosomal DNA results in a 798 bp product, 
whereas clones with the kanamycin cassette insertion result in a larger fragment at its 
predicted size of 1773 bp. 
Panel C: To test whether insertion of the disruption construct occurred in the correct 
location, primers HP0230 P3 and HP0232 P2 were used to amplify H. pylori chromosomal 
DNA. A product of 2253 bp in the wild-type and 3228 bp in the knockout demonstrated 
that the kanamycin cassette was inserted in the correct location.  
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3.1.2 Complementing hcpE::kan knockout mutant 
To study HcpE and its potential function in H. pylori pathogenicity, an hcpE::kan 
knockout mutant was previously constructed by A. Oberc. However, to determine whether 
the loss of the hcpE gene was the cause of the phenotype(s) observed and not due to 
downstream effects, an hcpE complement had to be constructed. The construct was 
designed to replace the disrupted hcpE gene within the H. pylori NCTC 11637 hcpE 
knockout mutant with a wild-type copy of hcpE. The construct also contained a 
chloramphenicol (CAT) cassette downstream of hcpE for selection purposes. All potential 
clones isolated from agar plates containing CAT were screened using PCR with primers 
HP0235P1 and HP0235P2 to determine whether the disrupted hcpE gene was replaced with 
the wild-type copy, as well as primers HP0235P1 and HP0232P1 to ensure that the entire 
construct recombined into the correct location within the chromosome. All clones screened 
contained the wild-type copy of hcpE (Figure 9B), however only clones 2 and 3 contained 
the entire complement construct in the correct orientation and location (Figure 9C). 
 To determine if our complement construct was capable of actually producing HcpE, total 
cell lysates from wild-type, hcpE knockout and hcpE complement were analyzed via 
SDS-PAGE separation and anti-HcpE Western blot (Figure 10). The hcpE complement 
clones 1 and 2 are able to produce HcpE at similar levels compared to wild-type, whereas 
clone 3 is not as prominent. It is important to note that the non-specific reactivity in the 
anti-HcpE Western blot is due to the anti-rabbit secondary antibody binding non-
specifically to proteins within the fraction. The size differences of HcpE observed in the 
complement clones compared to the wild-type is due to the fact that HcpE in the hcpE 
complement clones contain a C-terminal histidine tag for purification via nickel affinity  
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Figure 9: PCR screening of hcpE complement.  For all panels, diagrams are not to scale.   
Panel A: Diagram of the hcpE coding region (hp0235) in the knockout mutant and the 
complement showing all primer locations used in the PCR screening and the expected PCR 
amplicon sizes. 
Panel B: PCR amplification of potential hcpE complement clones using primers HP0235 
P1/P2. The hcpE knockout mutant was used as a control. Amplification indicates that the 
wild-type form of hcpE was successfully re-introduced into the chromosome in all clones 
tested. Amplification of hcpE from the knockout mutant chromosomal DNA results in a 
2273 bp product, whereas clones result in a smaller fragment at 1211 bp. 
Panel C: To test whether insertion of the complementation construct occurred in the 
correct location, primers HP0232 P1 and HP0235 P1 were used to amplify H. pylori 
chromosomal DNA. A product of 5505 bp in the knockout and 5303 bp in the complement 
demonstrated that the complement construct was inserted in the correct location within 
clones 2 and 3.  
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Figure 10: hcpE complement produces HcpE.  Total cell lysates from wild-type, 
hcpE::kan mutant and hcpE complement were analyzed via SDS-PAGE and anti-HcpE 
Western blot. The hcpE complement clones 1 and 2 produce HcpE at levels similar to wild-
type, whereas clone 3 is not a prominent as wild-type. PR: Ponceau Red, WB: Western 
blot.  
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chromatography. The added polyhistidine tag increases the molecular weight of the HcpE 
protein, resulting in increased size when run on an SDS-PAGE gel. 
3.1.3 DsbHP is soluble when over-expressed in E. coli 
Pure DsbHP was needed to determine its role as a potential oxidoreductase involved 
in the formation of disulfide bonds. DsbHP protein expressed from a previous expression 
construct was difficult to purify due to the presence of a C-terminal Flag tag that could not 
be used for purification purposes. Purification was conducted via anion exchange 
chromatography, which was not specific enough for our DsbHP protein, so contamination 
from other proteins that would non-specifically bind to the anion exchange column was 
observed. Thus, to be able to obtain pure DsbHP via nickel chromatography, a cleavable C-
terminal histidine tag was cloned onto the dsbHP gene after the Flag tag. The C-terminally 
histidine-tagged DsbHP was then transformed into E. coli BL21(DE3)pLys cells for 
expression via IPTG induction. 
To purify DsbHP, cultures were grown in LB at 37
◦C and induced with IPTG.  Cells 
were lysed with a cell disrupter, and the soluble and insoluble protein fractions were 
separated by centrifugation. The soluble proteins contained within the supernatant were 
passed through a nickel column for purification. Eluted fractions were analyzed by Western 
blotting with the anti-histidine antibody. Pure DsbHP was obtained and visualized at the 
expected size of 33 kDa (Figure 11A and B).  
3.1.4 E. coli DsbA and DsbG can be purified via nickel chromatography 
For the purpose of these studies, E. coli DsbA and DsbG were used as controls for 
comparative analysis with DsbHP to help determine whether DsbHP is an oxidase or  
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Figure 11: DsbHP can be expressed in E. coli. E. coli BL21(DE3)pLys cells were 
transformed with a pET vector containing DsbHP-Flag-His which is inducible via IPTG.  
Panel A: Expression of DsbHP was performed at 37
oC for 3 hours and was assessed using 
SDS-PAGE separation of total cell lysate and detected by anti-Histidine Western blot. 
DsbHP is observed at 33 kDA (asterisk). PR: Ponceau Red, WB: Western blot 
Panel B: DsbHP was purified using nickel affinity chromatography and the purity of the 
protein fractions was assessed using SDS-PAGE and Coomassie staining. DsbHP is 
observed at its expected size of 33 kDa.  
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isomerase in terms of the formation of disulfide bonds. The E. coli dsbA and dsbG genes 
were cloned into a pET30 vector with the same construct configuration as our new DsbHP 
to prevent any potential differences in activity, and then transformed into E. coli 
BL21(DE3)pLys cells for expression via IPTG induction. Cultures were grown in LB at 
37◦C, induced with IPTG and proteins purified as for DsbHP as described above. Eluted 
fractions were analyzed by Western blotting with the anti-histidine antibody (Figure 12A 
and B). Pure DsbA and DsbG were obtained and visualized at the expected size of 28 kDa 
and 31 kDa, respectively. Both DsbA and DsbG were visualized as 2 bands in both the 
total cell lysate and purified protein fractions, most likely representing the processed form 
of the proteins that made it through the Sec secretion system into the periplasm, and the 
un-processed form still containing its N-terminal signal sequence in the cytoplasm.  
3.1.5 Co-expressing DsbHP and HcpE simultaneously produces more soluble HcpE 
Expression of HcpE under previously optimized conditions resulted in the formation of 
mostly insoluble protein, with only a small amount of HcpE soluble. Due to the fact that 
pure soluble HcpE was required for this study, a vector encoding both dsbHP and hcpE was 
constructed. The hcpE gene was sub cloned into our pET30-DsbHP-Flag construct by PCR. 
The construct was designed so that both genes would be transcribed into the same RNA 
sequence but translated separately. HcpE and DsbHP were both over-expressed in the E. 
coli pET-30 plasmid. Following induction via IPTG, the total cell extracts as well as the 
soluble and insoluble fractions were analyzed for HcpE expression via anti-HcpE Western 
blot. Expression of HcpE at 37oC resulted in the formation of insoluble HcpE in both 
expression strains (Figure 13A). However, the E. coli containing the co-expression vector 
was able to produce soluble HcpE when IPTG induction occurred at room temperature,  
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Figure 12: DsbA and DsbG can be expressed via IPTG induction. E. coli 
BL21(DE3)pLys cells were transformed with a pET vector containing either dsbA or dsbG 
which is inducible via IPTG.  
Panel A: Expression of both DsbA and DsbG were performed at 37oC for 3 hours and total 
cell lysate was assessed using SDS-PAGE and anti-Histidine Western blot.   
Panel B: DsbA and DsbG were purified using nickel chromatography and purity was 
assessed using SDS-PAGE and Coomassie staining. Pure proteins were serial diluted to 
optimize the signal to noise ratio. DsbA was observed at its expected size of 28 kDa, and 
DsbG was observed at its expected size of 31 kDA.  
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whereas the original HcpE-His expression strain was still incapable of producing large 
amounts of soluble HcpE (Figure 13B). 
3.2 Investigation into the activity of DsbHP  
3.2.1 DsbHP is involved in the formation of disulfide bonds  
The function of DsbHP is predicted to be a putative E. coli DsbG based on structural 
homology, however, the function of DsbHP is still up for debate. To determine if DsbHP has 
DsbG activity, we investigated the capability of DsbHP to refold denatured and reduced 
lysozyme. HcpE has no known function, which makes it impossible to quantify DsbHP 
activity using reduced HcpE. Thus, lysozyme was chosen as a substrate due to the fact that 
lysozyme relies on four disulfide bonds for proper folding and stability (Eyles et al, 1994). 
Also, the use of denatured and reduced lysozyme as a substrate to test disulfide bond 
forming enzymes has been previously established in the literature (Puig and Gilbert, 1994; 
Puig et al, 1997).  
 Lysozyme was denatured and reduced using urea and β-mercaptoethanol 
respectively, and the reaction was quenched by dilution using acetic acid until a final 
concentration range of 1-10µM of lysozyme was obtained. Refolding reactions containing 
denatured and reduced lysozyme as well as DsbHP, E. coli DsbA , E. coli DsbG, or no 
enzyme were allowed to proceed for 1 hour before the reaction was quenched with acetic 
acid. E. coli DsbA and DsbG were used as comparative controls to help establish whether 
DsbHP activity is characteristic of DsbA oxidase, or DsbG isomerase activity. Lysozyme 
refolding activity was assessed via measurement of Micrococcus lysodeikticus lysis and  
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Figure 13: Co-expression of both HcpE and DsbHP results in more soluble HcpE. SDS-
PAGE analysis and Western blotting with anti-HcpE antibodies was performed on E. coli 
cell pellets containing either our co-expression or HcpE-His vector.  
Panel A: Expression was carried out at 37oC for 3 hours. Before induction half of the liquid 
culture was separated out to be used as a non-induction control. The anti-HcpE Western 
blot indicates that 37oC expression results in most of the HcpE remaining insoluble even 
in the co-expression strain.     
Panel B: Expression was carried out at room temperature for 3 hours to compare HcpE 
production to that done at 37oC. HcpE production at room temperature resulted in a 
decrease of insoluble HcpE, even more so in the co-expression strain, suggesting that the 
lower temperature as well as presence of DsbHP aided the folding and solubilization of 
HcpE.  
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was monitored spectrophotometrically at OD650nm. In the absence of lysozyme, the 
Micrococcus cells began to aggregate to the bottom of the well, which resulted in an 
increase in OD650nm (Figure 14A). When native lysozyme was added in the absence of any 
Dsb protein, rapid lysis of Micrococcus occurred (Figure 14A), which was to be expected. 
A slow linear decrease of OD650nm was observed when Micrococcus was in the presence of 
denatured and reduced lysozyme alone, which indicated that low levels of spontaneous 
refolding of lysozyme was occurring in the absence of Dsb protein (Figure 14, all panels). 
However, when either DsbHP, DsbA, or DsbG was incubated with the denatured and 
reduced lysozyme, an enhanced lysis of Micrococcus was observed similar to that seen 
with native lysozyme alone. This demonstrates that DsbHP is able to regenerate the disulfide 
bonds that are essential for lysozyme activity similar to that of both E. coli DsbA and DsbG, 
indicating that DsbHP has Dsb activity.  
3.2.2 DsbHP expression within E. coli is toxic 
 Dsb proteins play a crucial role in the periplasm. They are responsible for protein 
folding and maturation via disulfide bond formation, as well as maintaining the periplasmic 
oxidative status. We have demonstrated that DsbHP behaves like a Dsb protein, however, 
were unable to conclude whether its catalytic activity is similar to an oxidase or isomerase. 
Therefore, we wanted to determine whether DsbHP activity resembles DsbA or DsbG type 
of activity. To explore this, all 3 proteins were overexpressed separately. It was 
hypothesized that overexpression of a DsbA type protein would result in a more oxidative 
periplasmic environment resulting in a larger proportion of misfolded proteins that could 
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Figure 14: DsbHP is able to form disulfide bonds on reduced lysozyme. The ability of 
lysozyme to lyse Micrococcus was assessed by measuring the decrease in turbidity at 
OD650nm.  
Panel A: Optimized assay for DsbHP whereby spontaneous refolding of lysozyme was 
minimized and addition of DsbHP restored activity to reduced and denatured lysozyme 
(Lys) to levels similar to those obtained with native lysozyme.  
Panels B-C: Common reaction conditions show that addition of E. coli DsbG, and E. coli 
DsbA restored partial activity to reduced and denatured lysozyme.  
 
  
85 
 
 
1.5 
 
1.0 
                 
0.5 
 
0 
1.5 
 
1.0 
                 
0.5 
 
0 
1.5 
 
1.0 
                 
0.5 
 
0 
O
p
ti
ca
l 
D
en
si
ty
 (
O
D
6
0
0
n
m
) 
O
p
ti
ca
l 
D
en
si
ty
 (
O
D
6
0
0
n
m
) 
O
p
ti
ca
l 
D
en
si
ty
 (
O
D
6
0
0
n
m
) 
                                              
                               
                              
 
 
 
 
   
 0             15             30             45           60 
Time (min) 
No Lys, Dsb+     
No Lys, No Dsb        
Lys+, No Dsb            
Lys+, Dsb+ 
Native Lys 
DsbHP 
DsbA 
DsbG 
A. 
 
 
 
 
 
B. 
 
 
 
 
 
C. 
86 
 
 
potentially lead to cellular death. Overexpression of a DsbG type protein would most likely 
have no effect due to its nature of correcting improper disulfide bonds.  
The proteins DsbHP, DsbA, and DsbG were expressed in E. coli BL21(DE3)pLys 
via IPTG for 3 hours at 37oC. GDP-mannose 4,6-dehydratase (GMD), which is a protein 
involved in sugar biosynthesis, was used as a negative control to show that our observations 
were not solely due to induction alone. To determine if all of the proteins were expressed 
during induction, an anti-histidine Western blot was performed. All proteins expressed at 
the 3 hour time point were detected by Western blot, indicating successful overexpression 
(Figure 15). All cultures were then diluted and spot plated onto agar plates containing either 
various concentrations of IPTG or no IPTG at all. When grown on agar in the presence of 
IPTG, no growth for either E. coli expressing DsbHP or DsbA was observed. However, 
growth of E. coli expressing DsbG was observed for cells not pre-induced before plating 
(Figure 16). However, no growth for any E. coli strain that was pre-induced and grown in 
the presence of IPTG was observed, indicating that constant induction results in additional 
cellular stress leading to growth inhibition. Alternatively, all E. coli that was spotted onto 
agar with no IPTG had no difficulty growing. This indicated that the E. coli expressing 
either DsbHP or DsbA was more sensitive to IPTG exposure than DsbG or the control, 
causing the increased toxicity during protein expression.  
3.2.3 During reductive stress DsbHP exhibits DsbA-like behavior in E. coli 
Dsb proteins that are involved in oxidation pathways have previously been shown 
to be important in protecting against reductive stress due to the fact that dsbA mutants have 
been shown to be sensitive to dithiothreitol (DTT) in vitro (Kamitani et al, 1992; 
Roszczenko et al, 2012). It was hypothesized that when DTT is added to the growth 
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Figure 15: DsbHP, DsbA, and DsbG were all expressed in E. coli before being plated 
onto agar plates containing IPTG. The proteins DsbHP, E. coli DsbA, E. coli DsbG, and 
a control protein GMD that were pre-induced with IPTG before serial dilution and spot 
plating were analyzed via SDS-PAGE and anti-histidine Western blot. All proteins were 
expressed when pre-induced with IPTG, although GMD expression was below the 
detection level of anti-hisitdine Western blot.  All Dsb proteins were observed at their 
expected sizes of 33 kDa (DsbHP), 31 kDA (DsbG), and 28 kDa (DsbA). The control 
protein GMD was not expressed at detectable levels.  
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Figure 16: DsbHP has DsbA-like behavior when expressed in E. coli. The proteins 
DsbHP, E. coli DsbA, E. coli DsbG, and a control protein GMD were over-expressed under 
the same conditions and the cells were serial diluted before being spot plated. Dilutions 
were spotted onto plates containing either none or 0.15mM IPTG in decreasing order, as 
indicated by the triangles. DsbHP demonstrates the same toxic effects as DsbA due to the 
fact that pre-induction of protein expression resulted in less colonies compared with DsbG 
and the control protein.  
 
 
 
 
 
 
 
 
 
 
 
 
90 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non Induced 
Non Induced 
Pre-induced 
Pre-induced 
No IPTG 
IPTG 
Dilution 
 
DsbHP 
 
 
DsbG 
 
                        
DsbA 
 
 
Control 
Dilution 
              
DsbHP 
 
DsbG 
 
               
DsbA 
 
Control 
91 
 
 
medium, the periplasmic space would change from an oxidizing environment to a reducing 
one, resulting in many unfolded proteins. Over-expression of a DsbA like protein should 
be able to compensate for this change due to an increase in the potential to form disulfide 
bonds, whereas a DsbG like protein would have no effect because little to no spontaneous 
disulfide bonds would form that would require correction.  
E. coli expressing DsbHP, DsbA, and DsbG was grown and induced in the same 
conditions and time as described above. After induction, strains were diluted and spot 
plated onto agar containing 0, 5, 7.5, or 10mM DTT. Surprisingly, when E. coli cells were 
pre-induced with IPTG, no colonies were observed on plates containing 10 mM DTT, and 
the growth of E. coli expressing either DsbHP or DsbA were severely impaired compared 
to DsbG or the control when plated onto lower DTT concentrations (Figure 17). This 
indicated that the presence of DsbHP during exposure to DTT was not beneficial and 
actually resulted in a disadvantage. E. coli cells that were not pre-induced with IPTG before 
being plated onto the various concentration of DTT had no noticeable defects in growth 
other than no colonies were recovered on 10 mM DTT. This indicates that the endogenous 
expression of E. coli Dsb proteins was sufficient to counteract the effects of DTT up to10 
mM of DTT.  
An anti-histidine Western blot was performed on cells recovered after 16 hours post 
induction to determine if proteins expressed during pre-induction were still present within 
the cells (Figure 18). No reactivity was observed in the cells recovered from plates 
inoculated with pre-induced bacteria, indicating that all protein expression had stopped. 
Thus, as observed above, the toxic effects observed were due to the expression of the  
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Figure 17: Treatment with the reducing agent DTT results in DsbHP toxicity. The 
proteins DsbHP, E. coli DsbA, E. coli DsbG, and a control protein GMD (Cj1319) were 
over-expressed as described above. Dilutions were spotted onto agar containing either 0, 5 
or 7.5mM DTT in decreasing order, as indicated by the triangles. DsbHP demonstrates the 
same toxic effects as when pre-induced only except that the toxicity is more severe when 
DTT is in the media. DsbHP and DsbA displayed similar levels of toxicity when exposed to 
DTT, demonstrating a similar phenotype.  
 
 
 
 
 
 
 
 
 
 
 
 
93 
 
 
Dilution 
DsbHP 
               
DsbG 
               
DsbA 
           
Control 
Dilution 
DsbHP 
               
DsbG 
               
DsbA 
           
Control 
No DTT 
Dilution 
DsbHP 
               
DsbG 
               
DsbA 
           
Control 
With 5mM DTT 
With 7.5mM DTT 
No Induction Pre-induction 
 
 
     
    
   
   
 
  
94 
 
 
Figure 18: Dsb protein expression diminishes quickly after removal of IPTG. The 
proteins DsbHP, E. coli DsbA, E. coli DsbG, and a control protein GMD were analyzed via 
SDS-PAGE and anti-histidine Western blot 16hrs after spot plating.  
Panel A: SDS-PAGE analysis of E. coli expressing DsbHP, DsbA, DsbG, or GMD that 
were pre-induced with IPTG before serial dilution and spot plating.  
Panel B: SDS-PAGE analysis of E. coli expressing DsbHP, DsbA, DsbG, or GMD 16 hours 
after IPTG was removed from the medium. No histidine tagged proteins were observed in 
any of the cells 16 hours after the removal of IPTG from the media, indicating that protein 
expression had ceased and proteins from pre-induction had been turned over.  
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proteins during pre-induction. We currently do not understand the reason or mechanism 
behind the observed toxic effects of DsbHP and DsbA. Nevertheless, the results still clearly 
demonstrate that DsbHP has the same phenotype as DsbA, suggesting they may have similar 
enzymatic activity.   
3.2.4 The toxicity observed during DsbHP expression results in bacteriostasis 
The toxic effects observed while expressing DsbHP and DsbA demonstrated that 
these two enzymes may share similar catalytic activity. However, this phenotype had only 
been characterized during bacterial growth on agar plates and for only 1 time point. Thus, 
we repeated this experiment in liquid media to determine if this phenotype holds true over 
time.    
Culture and induction conditions were the same as described above. Once the 3 hour 
induction phase finished, growth of the cultures was monitored continuously at OD600nm 
every 20 minutes using the bioscreen apparatus. We observed, as when grown on agar 
plates, that pre-induction with IPTG while grown in the absence of DTT results in toxic 
effects that inhibits growth of E. coli with DsbHP and DsbA (Figure 19). Both DsbHP and 
DsbA had an extended lag phase compared to DsbG, 3 and 4 hours respectively. However, 
both DsbHP and DsbA were still able to eventually reach stationary phase.  When DTT was 
added to the liquid medium after the pre-induction with IPTG the lag phase for E. coli 
expressing either DsbHP or DsbA was even more severe, whereas the lag phase for DsbG 
was only slightly longer than compared to growth in the absence of DTT (Figure 19). 
Again, this demonstrates that DsbHP behaves similarly to DsbA rather than DsbG when 
expressed in E. coli. Also, expression of DsbHP and DsbA in liquid media suggests that the  
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Figure 19: Toxicity of DsbHP in liquid culture is bacteriostatic. The proteins DsbHP, E. 
coli DsbA, E. coli DsbG, and a control protein GMD were over-expressed in E. coli under 
the same conditions and the growth was monitored over a 20 hour period at OD600nm. DsbHP 
shows a DsbA-like toxic effect when pre-induced with IPTG as demonstrated by a 
lengthened lag phase. This effect was bacteriostatic since growth rates and final culture 
densities were similar for all strains. When DTT was added to the growth medium, the 
toxic effect was exaggerated.  
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toxicity generated by expressing these two proteins is bacteriostatic instead of 
bacteriocidal, due to the fact that in the presence or absence of DTT, the cells always 
reached stationary phase to the same degree as E. coli not expressing protein and not 
exposed to DTT.   
An anti-histidine Western blot was conducted to determine if expressed proteins 
were still present after induction had ceased (Figure 20). Western blot analysis indicated 
that proteins that were expressed during the pre-induction phase had already been turned 
over by 6 hours post induction. This strongly correlates with the duration of the extended 
lag phase observed in the E. coli expressing DsbHP and DsbA. Once expression has stopped 
and all proteins are eliminated from the periplasm, the cells are able to resume standard 
growth.  
3.2.5 DsbHP helps resist against oxidative stress within H. pylori  
Thus far we have established that DsbHP is capable of forming disulfide bonds and 
is responsible for oxidizing these bonds similarly to the E. coli oxidase DsbA. However, 
these experiments were conducted using E. coli and therefore the physiological activity or 
importance of DsbHP within H. pylori is still unknown. To help determine the activity of 
this enzyme within H. pylori, we constructed a mutant where we disrupted dsbHP with a 
kanamycin resistance cassette. This in itself demonstrated that dsbHP is not essential for 
survival as we were able to obtain knockout mutant clones.  
When grown in micro-aerobic conditions, the dsbHP knockout mutant was capable 
of retaining growth similarly to that of wild-type (Figure 21A). However, when exposed to 
atmospheric concentrations of oxygen a 10 fold decrease in cellular viability was routinely  
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Figure 20: Expression of Dsb proteins does not persist past 6 hours when IPTG is 
removed from the media. The proteins DsbHP, E. coli DsbA, E. coli DsbG, and a control 
protein WbpB were analyzed via SDS-PAGE and anti-histidine Western blot for protein 
expression after IPTG was removed from the medium.  
Panel A: SDS-PAGE analysis of E. coli expressing DsbHP, DsbA, DsbG, or WbpB that 
were pre-induced with IPTG before serial dilution.  
Panel B: SDS-PAGE analysis of E. coli expressing DsbHP, DsbA, DsbG, or WbpB 6 and 
16 hours after IPTG was removed from the media. No histidine tagged proteins were 
observed in any of the cells 6 hours after the removal of IPTG from the medium, indicating 
that protein expression had ceased and proteins from pre-induction are turned over quickly.  
Panel C: SDS-PAGE analysis of E. coli expressing DsbHP, DsbA, DsbG, or WbpB 6 hours 
after IPTG was removed and grown in the presence of DTT. It was speculated that the 
protein turnover within the periplasm would be reduced if DTT was present in the medium, 
however no histidine tagged proteins were visualized 6 hours post induction.  
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Figure 21: H. pylori dsbHP::kan mutant is sensitive to oxygen. The growth of H. pylori 
wild-type, dsbHP::kan and hcpE::kan mutants was assessed in both micro-aerobic and 
atmospheric conditions.  
Panel A: H. pylori wild-type, dsbHP::kan and hcpE::kan mutants were grown in micro-
aerobic conditions and growth was assessed via OD600nm. The data averaged from 9 
independent cultures per strain show that all strains grew to similar cell densities under 
micro-aerobic conditions.  
Panel B: The cultures obtained after 24h incubation in panel A were exposed to 
environmental atmosphere for 30 min followed by spot plating and further incubation in 
microaerobic conditions. The data are a representative of 6 independent experiments, each 
comprising 3 serial dilutions of each culture spot-plated in triplicate. The data show a 0.5-
1 log reduction in viability for the dsbHP mutant compared to both wild-type and hcpE 
mutant, suggesting that it was sensitive to oxygen exposure.  
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observed (Figure 21B). We hypothesize that this phenotype is the result of DsbHP having a 
DsbA-like activity and being involved in the oxidative protein folding under thiol- 
dependent redox conditions within the periplasm of H. pylori. The absence of DsbHP may 
result in increased susceptibility to oxidative stress.   
To further test whether DsbHP is involved in the protection against oxidative stress, 
we exposed wild-type H. pylori, dsbHP::kan and hcpE::kan knockout mutants to various 
concentrations of hydrogen peroxide (H2O2). We hypothesized that if DsbHP is involved in 
the protection against oxidative stress by maintaining periplasmic homeostasis, then the 
absence of DsbHP while in the presence of H2O2 would result in less oxidative tolerance 
leading to more cellular death. H. pylori wild-type and knockout mutants were exposed to 
various concentrations of H2O2 for 30 minutes in micro-aerobic conditions.  Cells were 
then diluted and spot plated onto agar and allowed to grow in micro-aerobic conditions for 
5-7 days, or until colonies were observed. Results indicated that H. pylori is highly 
sensitive to oxidative stress when dsbHP is disrupted due to the fact that growth of the dsbHP 
knockout mutant was completely absent when exposed to 125mM H2O2, as well as 
significantly reduced when exposed to 100mM H2O2. Whereas the H. pylori wild-type was 
recovered readily and displayed no real defect in growth when exposed to H2O2 (Figure 
22). The hcpE knockout mutant was used as a control to determine if the phenotype we 
observed was solely due to the lack of DsbHP, or the reduction of HcpE due to dsbHP 
disruption. The fact that we were able to recover our hcpE knockout mutant at similar levels 
compared to wild-type demonstrated that this increased susceptibility to H2O2 was only 
due to the lack of DsbHP. 
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Figure 22: H. pylori is more sensitive to H2O2 in the absence of DsbHP. H. pylori wild-
type, dsbHP knockout mutant and hcpE knockout mutant were exposed to 75, 100, and 
125mM H2O2. The dsbHP knockout mutant displayed enhanced sensitivity compared to the 
wild-type and hcpE mutant based on number of colonies observed. This demonstrates that 
DsbHP is important in the resistance to oxidative stress and in maintaining oxidative 
homeostasis within the periplasm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
106 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dilution 
Wild-type           
               
dsbHP mutant 
                
hcpE mutant 
Dilution 
Wild-type 
               
dsbHP mutant 
                
hcpE mutant 
No H2O2       75mM 
       100mM          125mM 
107 
 
 
3.2.6 Complementation of DsbHP restores H2O2 resistance 
To determine whether the phenotypes we observed when H. pylori devoid of DsbHP 
during H2O2 exposure were specific to the DsbHP protein and not polarization or 
downstream effects due to dsbHP disruption, we repeated the same experiment with our 
dsbHP complemented strain. The dsbHP complement was constructed by Brandon Oickle 
with the same strategy as the hcpE complement (refer to section 3.1.2).  
As expected, the dsbHP complement was able to resist the effects of H2O2 better 
than the dsbHP::kan knockout mutant, and at similar levels compared to WT (Figure 23). 
However, it is important to note that the recovery of dsbHP complement was always less 
than that of the wild-type, demonstrating a partial restoration of the wild-type phenotype. 
This further supports that DsbHP has catalytic activity similar to that of DsbA, and that the 
phenotypes observed in the dsbHP::kan knockout mutant were due specifically to the 
absence of DsbHP production within the cell.   
3.2.7 H. pylori devoid of DsbHP is more sensitive to DTT exposure 
We have previously established an enhanced reduction in viability when E. coli expressing 
DsbHP was exposed to various concentrations of DTT.  To determine if this phenotype 
would persist in H. pylori. It was hypothesized that the dsbHP::kan knockout mutant would 
be able to survive better in the presence of DTT.  
H. pylori wild-type, dsbHP::kan, and the dsbHP complement were grown on agar 
plates for 48 hours until growth was confluent. Cells were then diluted and plated onto agar 
containing 0, 8, 10, or 12mM DTT and allowed to grow in micro-aerobic conditions until  
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Figure 23: H2O2 resistance is restored upon DsbHP complementation. H. pylori wild-
type, dsbHP knockout mutant and dsbHP complement were exposed to 75, 100, and 125mM 
H2O2. The dsbHP knockout mutant displayed enhanced sensitivity compared to the wild-
type based on number of colonies observed. Restoration of dsbHP restored resistance as the 
number of colonies observed was similar to wild-type. This demonstrates the importance 
of DsbHP in maintaining oxidative homeostasis within the periplasm.   
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colonies were visible. None of the strains were sensitive to the DTT up to 8mM 
concentration, however, all strains displayed sensitivity to DTT at 12mM concentration 
(Figure 24). Surprisingly, the dsbHP knockout mutant displayed enhanced sensitivity to 
DTT compared to the WT. Similarly to when H. pylori was exposed to H2O2, this severe 
loss in viability was specific to DsbHP as the hcpE knockout mutant did not experience such 
a drastic loss in viable cells. This interaction demonstrates that DsbHP is important for the 
resistance to reductive stress, and that the toxicity witnessed in E. coli was most likely due 
to the additional stress and burden of protein expression than the actual DTT itself.   
3.2.8 Complementation of DsbHP reduces cellular death by reductive stress 
As with the H2O2 experiments, we wanted to determine if restoration of DsbHP 
would restore resistance to reductive stress comparable to WT. The same experiment was 
repeated as described above other than the fact that the dsbHP complement was used instead 
of the hcpE knockout mutant. As expected, the dsbHP complement resisted the effects of 
DTT better than the dsbHP::kan knockout mutant, and at similar levels compared to wild-
type (Figure 25). This result further supports the conclusion that the phenotypes observed 
in the dsbHP::kan knockout mutant were due specifically to the absence of DsbHP 
production within the cell.   
3.3 Intrinsic activity of DsbHP 
3.3.1 HcpE is secreted into the extracellular environment via outer membrane vesicles 
Outer membrane vesicles (OMVs) are spherical structures composed of a bilayer 
membrane derived from the outer membrane of the cell. When they are extruded from the  
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Figure 24: DsbHP is important for survival of H. pylori when exposed to reducing 
stress. To determine the importance of DsbHP during reductive stress, H. pylori wild-type, 
dsbHP and hcpE knockout mutants were grown to the same cell densities, then spot plated 
onto agar containing 0, 8, 10, or 12mM DTT to assess viability. All growth was performed 
in micro-aerobic conditions. The dsbHP mutant displayed less viability compared to the 
wild-type and hcpE mutant, demonstrating that the increased susceptibility was DsbHP 
specific.   
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Figure 25: DsbHP complementation nullifies DTT sensitivity. H. pylori wild-type, dsbHP 
knockout mutant and dsbHP complement were all grown to the same densities, then spot 
plated onto agar containing 0, 8, 10, or 12mM DTT to assess viability. All growth was 
performed in micro-aerobic conditions. Complementation of dsbHP back into the bacterial 
chromosome restored resistance to DTT comparable to wild-type levels.  
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cell they package some of the periplasmic contents within. OMVs have been shown to have 
important roles in virulence by trafficking toxins and other virulence factors to their targets. 
In H. pylori, virulence factors such as VacA have been shown to target host cells though 
OMVs (Ilver et al, 2004). Thus, due to the fact that HcpE has been observed in H. pylori 
culture supernatant, we also wanted to determine whether it is also packaged into OMVs.  
To test this, supernatants from H. pylori cultures grown in liquid medium were 
ultra-centrifuged to collect membrane fragments and potential OMVs. Once recovered, 
membrane fragments were analyzed by anti-HcpE Western blot and indicated the presence 
of HcpE within the sample (Figure 26). The membrane fragments consisting of potential 
OMVs were also treated with proteinase K to be able to distinguish between proteins and 
the O-antigen, as well as compare the protein profiles to that of inner membranes (IM) and 
outer membranes (OM) to help ascertain whether the membrane fragments isolated were 
derived from either IM or OM (Figure 27). Analysis via silver staining revealed that the 
potential OMVs were composed of both LPS and O-antigen (Figure 27D). 
Results demonstrated that HcpE was present in the isolated membrane fragments 
of wild-type and the dsbHP::kan mutant, however, the amount of HcpE in the dsbHP 
mutant was drastically reduced. We also demonstrated that the membrane fragments were 
most likely derived from the OM of H. pylori, as two distinct protein bands that are present  
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Figure 26: HcpE is found within outer membrane vesicles. Outer membrane vesicles 
were analyzed to determine whether HcpE could be packaged and secreted outside the cell. 
SDS-PAGE analysis of the membrane pellets obtained by ultracentrifugation of wild-type, 
dsbHP and hcpE mutant culture supernatants. Detection of HcpE was done by Western 
blotting with anti-HcpE antibodies. HcpE is marked with an asterisk (*). 
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Figure 27: Outer membrane vesicle fraction is derived from the outer membrane.  
Panel A: SDS-PAGE analysis of inner and outer membrane fractions of wild-type, hcpE 
and dsbHP mutants stained with Coomassie brilliant blue to detect protein profile. Total 
membranes were obtained by ultracentrifugation of whole cell lysate, and the inner and 
outer membranes were separated using lauryl sarcosyl followed by ultracentrifugation to 
pellet the outer membranes.  
Panel B: Silver stain analysis of the same samples as described in panel A.  
Panel C: Silver stain analysis of the same samples as described in panel A treated with 
proteinase K (PK).   
Panel D: SDS-PAGE analysis of the pellets obtained by ultracentrifugation of culture 
supernatants of wild-type, hcpE::kan and dsbHP::kan mutants that were either treated with 
proteinase K or left untreated.  
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at 26 and 32 kDa within the IM fraction are not present in either OM or membrane 
fragments. In addition, membrane samples obtained by ultracentrifugation of culture 
supernatants from wild-type, dsbHP and hcpE mutants were analyzed by electron 
microscopy after uranyl acetate staining. Spherical membrane-bound structures of 75 to 
150 nm in width that are characteristic of outer membrane vesicles were observed in all 
strains (Figure 28). This demonstrates that the isolated membrane fragments containing 
HcpE are in fact OMV particles, and that the presence of HcpE in the OMVs relies to a 
large extent on DsbHP. 
3.3.2 DsbHP is required for secretion of HcpE 
The Creuzenet lab previously demonstrated that DsbHP is an interacting partner for 
HcpE, and that this interaction leads to the folding and solubilization of HcpE. Due to the 
fact that HcpE is a protein that contains 9 disulfide bonds that are important for its structure, 
and it is secreted into the outer matrix, we hypothesized that this interaction between DsbHP 
and HcpE would be required for proper secretion. To test this, anti-HcpE Western blot 
analysis was conducted using our dsbHP knockout mutant. Various fractions were analyzed 
to determine if there were any differences in the abundance of HcpE within different 
locations within the cell.    
Cellular fractionation was performed by subjecting H. pylori to lysozyme treatment 
in 0.5 mM MgCl2 and 30% sucrose to form spheroplasts. The spheroplasts were pelleted 
by centrifugation at 4,000 g for 10 minutes and the supernatant containing the periplasmic 
proteins was retained for analysis. The spheroplasts were lysed by re-suspension in water 
and vortexing using glass beads. The cytoplasmic protein fraction was obtained by  
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Figure 28: Electron micrographs of outer membrane vesicles. Samples were negatively 
stained with uranyl acetate.  
Panel A: Wild-type. Bar = 50 nm. 
Panel B: Wild-type. Bar = 10 nm. 
Panel C: dsbHP::kan. Bar = 50 nm. 
Panel D: hcpE::kan. Bar = 50 nm.  
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centrifugation at 12,000 g for 30 minutes. The outer membrane proteins were recovered by 
ultracentrifugation of the culture supernatant. All fractions were analyzed by SDS-PAGE 
and anti-HcpE Western blotting.  
HcpE was in very low abundance in the total cellular fraction of our dsbHP knockout 
mutant compared to H. pylori wild-type (Figure 29A). HcpE was observed within the 
periplasmic fraction of the dsbHP knockout mutant, but again in lower amounts compared 
to wild-type. The fractions containing outer membrane vesicles were also analyzed to 
determine if the absence of DsbHP would result in less secretion of HcpE through OMVs. 
As expected, much less HcpE was present in the OMVs obtained from the dsbHP knockout 
mutant than compared to the wild-type. Due to cellular lysis during spheroplast formation, 
a pure periplasmic fraction could never be obtained. Nonetheless, the presence of HcpE 
within the periplasmic fraction and absence in the cytoplasmic fraction of the dsbHP 
knockout mutant indicates that the periplasmic fraction was enriched, and was 
contaminated with very few cytoplasmic proteins. This is also further supported by the fact 
that very little urease activity was observed in the periplasmic fraction (Figure 29B); urease 
is a cytoplasmic protein responsible for the hydrolysis of urea into ammonium and carbon 
dioxide. The presence of urea within the periplasmic fraction would indicate cellular lysis 
had occurred during spheroplasting.    
This same phenotype was observed in the dsbHP knockout mutant of the H. pylori 
Sydney strain (SS1). This strain is used for in vivo animal studies as it has been adapted 
over time to colonize mice. The dsbHP knockout mutant produced and secreted very little 
HcpE compared to the wild-type (Figure 30). Taken together, these data indicate that DsbHP 
is involved in the production and secretion of HcpE. HcpE appears to be targeted to the 
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Figure 29: DsbHP is involved in the production and secretion of HcpE in H. pylori. 
Wild-type and dsbHP knockout mutant whole cells we subjected to lysozyme digestion in a 
sucrose gradient to form spheroplasts, allowing for the extraction of periplasmic proteins. 
Spheroplasting was monitored every 20 minutes by bright field microscopy to prevent total 
cell lysis.  
Panel A: Ponceau S red staining and Western blotting for the presence of HcpE using anti-
HcpE antibodies. Abbreviations: Cyto: cytoplasmic proteins. Peri: periplasmic proteins. 
The disruption of dsbHP leads to reduction in the total production of HcpE.  Most of the 
HcpE produced appears within the periplasmic fraction, with very little observed within 
the OMVs. PR: Ponceau Red, WB: anti-HcpE Western blot.  
Panel B: Urease activity of the various fractions was tested to assess cellular lysis. A small 
amount of urease activity was observed in the periplasmic fraction, indicating potential 
contamination by cytoplasmic proteins during spheroplasting. However, due to the fact that 
HcpE was only found in the periplasmic fraction of the mutant and not in the cytoplasm, 
indicates that the periplasmic fraction had been enriched and that the protein translocates 
to the periplasm as expected.  
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Figure 30: Secretion of HcpE is also impaired in the absence of DsbHP in strain SS1. 
SDS-PAGE analysis and anti-HcpE Western blotting of total cells (top panels) or culture 
supernatants (bottom panels) of wild-type or dsbHP or hcpE knockout mutants shows 
decreased production and secretion of HcpE in the dsbHP mutant. HcpE-His is purified 
recombinant protein that served as a positive control for Western blotting. PR: Ponceau 
red. WB: Anti-HcpE Western blot. 
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periplasmic space, however, in the absence of DsbHP remains trapped there and is most 
likely targeted for degradation. To ensure that the absence of HcpE in the OMVs of the 
dsbHP knockout mutant was specific to DsbHP itself and not due to potential pleotropic 
effects which could affect OMV secretion, analysis of LPS profiles of the OMVs was 
conducted using silver nitrate (Figure 27D). The dsbHP knockout mutant displayed both 
normal LPS and protein profiles compared to wild-type demonstrating that OMV 
packaging and membrane composition had not changed.   
3.3.3 HcpE is produced and secreted from H. pylori clinical isolates 
We have demonstrated that HcpE is secreted into the supernatant as well as secreted 
through OMVs from H. pylori cultured in liquid media. The fact that antibodies to HcpE 
and other Hcp family members are present in the serum of patients infected with H. pylori 
suggests that Hcp family members are produced within the host. Thus, we wanted to 
determine if strains isolated from infected patients produced and secreted HcpE, as well as 
determine if there is any differences in HcpE expression among different clinical strains 
isolated from patients with various onset of H. pylori associated disease. To test this, anti-
HcpE Western blot analysis was conducted on 13 different clinical isolates. Total cell 
lysate, culture supernatant as well as OMVs were analyzed to determine if there were any 
differences in the abundance of HcpE among various strains.    
 Clinical isolates were grown on Columbia agar in micro-aerobic conditions until 
growth was confluent. Strains were then sub-cultured into Brucella broth supplemented 
with β-cyclodextrin and antibiotics and grown for 16 hours in micro-aerobic conditions. 
Cells were harvested and supernatants were collected. Total cell lysate and culture 
supernatants were analyzed via SDS-PAGE and anti-HcpE Western blot to determine the 
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presence of HcpE. All clinical isolates tested produced and secreted HcpE (Figure 31). 
HcpE was observed in all fractions tested including cell lysate and supernatants. However, 
the clinical isolates obtained from patients diagnosed with ulcer disease seemed to produce 
more HcpE compared to the other strains analyzed. This result is further supported by the 
fact that the Creuzenet lab has demonstrated that patients with high antibody titers to HcpE 
had a greater chance of developing duodenal ulcer disease than those who displayed low 
HcpE titers (Unpublished).  
3.4 Influence of HcpE on the production of inflammatory mediators 
3.4.1 H. pylori impaired in HcpE production is deficient in colonization  
H. pylori has been studied extensively, however, its ability to persist and interact 
with the host is still not fully understood. The discovery of SLR motifs within HcpE 
suggests they are interacting with host cells and/or proteins (39). However, the process or 
cells with which they interact has not been studied. Thus, to determine the effect of HcpE 
on the host, in terms of both colonization and recruitment of inflammatory mediators, H. 
pylori wild-type as well as hcpE and dsbHP knockout mutants need to be studied in vivo. 
H. pylori Sydney strain (SS1), is a mouse adapted strain which was repeatedly orally 
passaged through C57BL/6 mice until it was capable of efficiently colonizing mice for long 
periods of infection (≤ 8 months) (Lee et al, 1997). Colonization results in inflammation 
of the gastric mucosa within 4-5 weeks, increased neutrophil recruitment, and expression 
of Major Histocompatibility Complex II (MHC II) class antigens. However, peptic 
ulceration and gastric cancers have not been observed (Fan et al, 1998). As in humans, the 
gastric inflammation in conjunction with immune activation is ineffective at clearing  
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Figure 31: HcpE produced and secreted by H. pylori isolated from infected patients.   
The presence and abundance of HcpE was analyzed in clinical isolates obtained from 
patients diagnosed with various gastric disorders.  
PanelA: Ponceau S red staining and Western blotting for the presence of HcpE using anti-
HcpE antibodies in total cell lysate of 16 clinical isolates. HcpE is present in the cell lysate 
of all clinical strains tested, with the strains obtained from ulcer patients displaying the 
highest abundance of HcpE.  
Panel B: Ponceau S red staining and Western blotting for the presence of HcpE using anti-
HcpE antibodies in culture supernatants of 12 clinical isolates. HcpE is present in the 
supernatant of all clinical strains tested, with the strains obtained from ulcer patients 
displaying the highest abundance of HcpE.  
WT: wild-type, KO: hcpE::kan knockout mutant, GU: Gastric ulcer, DU: Duodenal ulcer, 
G: Gastritis, A: Atrophy, PR: Ponceau Red, WB: anti-HcpE Western blot. 
 
 
 
 
 
 
 
131 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A. 
 
 
 
 
 
 
 
 
 
 
 
 
B. 
WT KO 1    2     3   4     5    6     7    8    9    10   11           Strain 
WT    KO    12     13      14      15      16               Strain 
WT     KO     1      2       3       4       5       6        7                Strain 
WT     KO      8        9        10       11         12                 Strain 
GU  GU   GU  DU   DU  GU   A     A     G      G    A          Patient Disease 
G          A         A           G         G                          Patient Disease 
GU     GU    DU       DU     GU        A       A                     Patient Disease 
G         G           A          G              G                      Patient Disease 
132 
 
 
H. pylori. Thus, this mouse model has been successfully developed to study infections in 
vivo which show similar characteristics to infection in humans.  
Hcps are highly conserved within H. pylori strains, thus must be beneficial to their 
perseverance. Other Hcp proteins such as HcpA and HcpB have been implicated in the 
production of pro-inflammatory cytokines, suggesting they may play a role in H. pylori 
induced gastritis. To determine whether HcpE impacts colonization or inflammation, 
C57BL/6 mice were intra-gastrically inoculated with strain SS1 wild-type and knockout 
mutants as described by Ferrero et al. Briefly, mice were orally gavaged with 109 bacteria 
3 times, once every other day for the course of a week. Infection was allowed to proceed 
for 4 and 6 weeks post gavage before mice were sacrificed. To assess infection, plating of 
stomach homogenate for cfu counting was conducted. After being harvested and divided 
into 2 halves, the murine stomach tissue was placed into PBS buffer with antibiotics and 
homogenized with an electric homogenizer. After homogenization, the gastric homogenate 
was diluted 10 and 100 fold, and each dilution was plated onto Columbia blood agar. Plates 
were incubated in micro-aerobic conditions for 5-7 days. Colonization was also assessed 
via histological sections of stomach tissue that were prepared, and observed using light 
microscopy. The dsbHP and hcpE knockout mutants in SS1 strain had not been previously 
established, thus knockout mutants were constructed using the same constructs and 
technique described in section 2.10. 
The presence of H. pylori within the gastric mucosa of mice gavaged with either 
wild-type, dsbHP::kan, or hcpE::kan knockout mutants was not detected via plating of the 
gastric homogenate. No colonies from mice gavaged with either strain were recovered. 
However, Warthin-Starry staining, which is a silver nitate based stain originally used to 
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detect spirochetes, established the presence of H. pylori within the gastric mucosa of 
infected mice (Figure 32). Both dsbHP and hcpE knockout mutants had impaired 
colonization compared to wild-type based on total cells visualized and counted within the 
processed tissue, with the dsbHP knockout mutant being the most attenuated (Figure 33). 
This trend was observed for mice sacrificed at both 4 and 6 weeks post gavage, indicating 
that H. pylori is still capable of colonization over long periods when devoid of either DsbHP 
or HcpE, but colonization is significantly impaired compared to wild-type. We currently 
do not fully understand why this defect in colonization is occurring, but we hypothesize 
that motility may be a factor due to the fact that both knockout mutants have impaired 
motility compared to wild-type (Figure 34). The dsbHP knockout mutant is less capable of 
colonizing than the hcpE mutant, however retains more motility. Thus there is another 
factor(s) that is contributing to the decreased colonization observed in the dsbHP knockout 
mutant.  
3.4.2 Effects of HcpE on interaction of H. pylori with splenocytes 
3.4.2.1 Pro-inflammatory cytokine IFN-γ is secreted from splenocytes exposed to H. 
pylori cells 
 
To determine the effects of HcpE on the inflammatory response, splenocytes were 
isolated from mice colonized with H. pylori or not, and subjected to incubation with 
bacteria. Splenocytes were inoculated with wild-type, dsbHP and hcpE knockout mutants 
at a multiplicity of infection of either 1, 0.5, or 0.1. Low MOIs were chosen due to the fact 
 
134 
 
 
Figure 32: H. pylori wild-type, dsbHP and hcpE knockout mutants are able to infect 
mice. Comparison of the ability of H. pylori wild-type, dsbHP and hcpE knockout mutants 
to colonize mice. Sections of murine gastric tissue analyzed by bright field microscopy for 
the presence of H. pylori. H. pylori was observed in all mice infected with either wild-type, 
dsbHP or hcpE knockout mutants. Sections were stained with Warthin-Starry stain to 
visualize H. pylori. H. pylori cells are highlighted by the red arrow.     
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Figure 33: H. pylori wild-type colonizes better than both dsbHP and hcpE knockout 
mutants. To compare the colonization ability of our wild-type as well as dsbHP and hcpE 
knockout mutants, total cell counts observed within gastric tissue samples of mice that were 
sacrificed 4 and 6 weeks post gavage were averaged between mice, and multiplied by the 
length of an average murine stomach to produce a calculated estimate of total cells within 
the gastric mucosa. A total of 2 sections per mouse from a total of 6 mice for each time 
point post gavage were used in the calculations. *P<0.05, **P<0.01, ***P<0.001, N.S.: 
Not significant.  
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Figure 34: H. pylori devoid of HcpE is less motile than wild-type. Comparison of the 
ability of H. pylori strain SS1 wild-type, dsbHP and hcpE knockout mutants.  
Panel A: H. pylori strain SS1 wild-type, dsbHP and hcpE knockout mutants were inoculated 
into agar plates containing 0.1% Bacto Agar to test how motile they were by measuring 
their ability to move through the agar. Differences in motility were measured by the 
diameter of the outward growth from the initial site of inoculation. Both dsbHP and hcpE 
knockout mutants displayed impaired growth compared to wild-type.  
Panel B: Quantification of differences in motility. Results are representative of 3 
independent experiments. *P<0.05, N.D.: Not detected.    
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that H. pylori has been shown to induce apoptosis of splenocytes at high MOIs (Bussiere 
et al, 2006). After 2 hours of incubation, splenocytes were stimulated with E. coli LPS and 
supernatants were collected after 12 and 24 hours. Stimulation with E. coli LPS was needed 
as H. pylori LPS has low immunogenic activities, making it difficult to measure differences 
in inflammatory responses (Muotiala et al, 1992; Nielson et al, 1994). Splenocytes were 
stimulated with 5 different concentrations of LPS (Q1-Q5) that were diluted 3 fold for each 
subsequent concentration. This was done to obtain a range of LPS concentrations to ensure 
we could obtain the best dose to response ratio possible. Based on experiments comparing 
production of IFN-γ after exposure to H. pylori cells or E. coli LPS, activation of 
splenocytes was lower with H. pylori cells than when E. coli LPS was added (data not 
shown). When the splenocytes are exposed to H. pylori before being exposed to LPS, there 
is a dose dependent reponse to H. pylori cells in relation to LPS, in the splenocytes isolated 
from naïve mice, but lower MOIs resulted in less LPS response compared to high MOIs 
(Figure 35A). This dose dependence was not observed in the splenocytes obtained from 
mice previously exposed to H. pylori dsbHP::kan mutant (Figure 35B). However, cells from 
H. pylori wild-type, dsbHP or hcpE knockout mutants did not show any significant 
difference in their abilities to modulate the capacity of E. coli LPS to initiate an IFN-γ 
response when exposed to splenocytes from naïve mice (Figure 35A) or mice previously 
exposed to H. pylori (Figure 35B). The same was observed using splenocytes pre exposed 
to H. pylori wild-type, dsbHP::kan, and hcpE::kan mutants (data not shown). This suggests 
that the lack of HcpE has no effect on the ability of H. pylori cells to induce an IFNγ 
response. However, it should be noted that H. pylori encodes many virulence factors 
responsible for initiating inflammatory responses such as CagA and VacA. Thus,  
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Figure 35: H. pylori knockout mutant cells activate splenocytes similar to wild-type. 
Exposure of splenocytes for 12 or 24 hours with wild-type, dsbHP::kan and hcpE::kan H. 
pylori modulates the ability of splenocytes to respond to LPS exposure via release of pro-
inflammatory cytokine IFN-γ.  
Panel A: Infection of naïve splenocytes for 12 or 24 hours with wild-type, dsbHP::kan and 
hcpE::kan H. pylori. There was no difference between the wild-type or knockout mutants. 
Calculations done by Dr. Creuzenet. 
Panel B: Infection of splenocytes from mice previously exposed to dsbHP::kan knockout 
mutant for 12 or 24 hours with wild-type, dsbHP::kan and hcpE::kan H. pylori. ELISA by 
N. Bronnec and calculations done by Dr. Creuzenet. 
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expression of these virulence factors may over-shadow the effects of HcpE resulting in the 
inability to see differences. To address this, we decided to investigate the effects of pure 
HcpE as well as culture supernatants of wild-type and both mutants on IFN-γ production. 
3.4.2.2 HcpE induces production of IFN-γ when secreted outside the cell  
 
The experiment described above was repeated using culture supernatants obtained 
from H. pylori grown in liquid medium as well as pure HcpE protein. Culture supernatants 
were obtained by growing H. pylori wild-type, dsbHP and hcpE knockout mutants in liquid 
medium as described in section 3.3.2. Splenocytes were inoculated with culture 
supernatants at 1, 3, and 5X concentrations.  
Exposure of splenocytes with culture supernatants was carried out in the same 
manner as described above. Splenocyte supernatants that were collected 12 and 24 hours 
post infection were analyzed for the production of IFN-γ by ELISA. The IFN-γ response 
was lower in the splenocytes exposed to the dsbHP and hcpE knockout mutant culture 
supernatants compared to wild-type. This trend was true for splenocytes isolated from both 
naïve mice (Figure 36A) and mice previously exposed to the dsbHP::kan knockout mutant 
(Figure 36B). Both knockout mutants displayed a decreased response in IFN-γ in all 
concentrations of both culture supernatants as well as LPS tested, with the hcpE knockout 
mutant showing the most prominent decrease in IFN-γ production in the splenocytes 
previously exposed to H. pylori (Figure 36B), however the dsbHP knockout mutant 
displayed the most prominent decrease in the naïve splenocytes (Figure 36A). This 
suggests that HcpE is able to modulate the response of splenocytes to LPS as the reduction 
or absence of HcpE within the culture supernatant resulted in less IFN-γ production.  
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Figure 36: H. pylori knockout mutant supernatants reduce the response of splenocytes 
to LPS compared to wild-type. Exposure of splenocytes for 12 or 24 hrs to LPS in the 
presence of H. pylori wild-type, dsbHP::kan and hcpE::kan H. pylori culture supernatants 
lead to the release of pro-inflammatory cytokine IFN-γ. This effect was lower in both 
mutants compared to the wild-type, suggesting that HcpE is involved with modulation of 
the response of splenocytes to LPS. 
Panel A: Exposure of naïve splenocytes for 12 or 24 hrs with wild-type, dsbHP::kan and 
hcpE::kan H. pylori culture supernatants. Calculations done by Dr. Creuzenet.  
Panel B: Exposure of splenocytes (taken from mice previously exposed to dsbHP::kan 
mutant) for 12 or 24 hrs with wild-type, dsbHP::kan and hcpE::kan H. pylori culture 
supernatants. ELISA by N. Bronnec and calculations done by Dr. Creuzenet. 
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For exposure to pure HcpE protein, HcpE was expressed in E. coli BL21(DE3)pLys 
via induction with 0.15mM IPTG and purified using nickel affinity chromatography. The 
protein DdahB was provided by H. Barnawi and used as a control. Both proteins were 
added to splenocytes at concentrations of 75, 125, and 200 ng, and production of IFN-γ 
was measured directly without further addition of LPS. E. coli LPS is able to easily activate 
the innate and adaptive immune system. Thus, to prevent accidental contamination from 
E. coli LPS during lysis and protein purification, the purified HcpE as well as the control 
protein were run through a polymyxin B column to remove any LPS.  The purified proteins 
were then split into 2 equal fractions and one fraction was treated with Proteinase K for 2 
hours to degrade the proteins into peptides. This was done as an additional control to 
demonstrate that the HcpE protein and not an additional contaminant within the sample 
would be the cause for activation of splenocytes. To ensure full proteolysis and removal of 
LPS was successful, protein fractions of both HcpE and control protein DdahB were 
analyzed via separation by SDS-PAGE and stained with silver nitrate (Figure 37). Proteins 
treated with Proteinase K were digested into smaller peptides and the absence of Lipid A 
and O-antigen within the samples indicated that no LPS contamination was present.  
Splenocytes that were exposed to purified HcpE produced significantly more IFN-
γ than when exposed to the control protein DdahB (Figure 38). Little to no IFN-γ 
production was observed in the control protein as well as in the samples that were degraded 
with proteinase K in both the naïve splenocytes (Figure 38A) as well as the splenocytes 
from mice previously exposed to dsbHP::kan knockout mutant (Figure 38B). This suggests 
that the purified HcpE protein alone was responsible for the direct induction of a  
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Figure 37: HcpE purified via nickel affinity chromotography is not contaminated 
with trace amount of LPS. To test whether our purified HcpE as well as control protein 
DdahB were contaminated with E. coli LPS after treatment with the polymyxin B column, 
various dilutions of each sample were analyzed by SDS-PAGE and stained with either 
Coommassie brilliant blue or silver nitrate. No LPS was observed in any samples indicating 
any potential LPS contamination had been removed by the polymyxin B column. Both 
HcpE and DdahB were not fully digested but all proteins within the sample had been 
partially digested into smaller peptides. HcpE and DdahB were observed at 40 kDa and 38 
kDa respectively.  
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Figure 38: Pure HcpE activates splenocytes. Exposure of splenocytes for 12 or 24 hrs 
with pure HcpE or DdahB at 25, 75, 125, and 200 ng that was treated with either proteinase 
K (PK) or non-treated lead to the release of pro-inflammatory cytokine IFN-γ. IFN-γ 
release was observed for pure HcpE that was not treated with proteinase K, where as little 
to no IFN-γ response was observed for the control protein or HcpE that was treated with 
proteinase K. This effect suggests that only native HcpE is involved with activation of 
splenocytes, as degraded HcpE as well as the control protein were unable to initiate an IFN-
γ response.  
Panel A: Infection of naïve splenocytes for 12 or 24 hrs with pure HcpE or DdahB at 75, 
125, and 200 ng that was treated with either proteinase K (PK) or non-treated lead to the 
release of pro-inflammatory cytokine IFN-γ.  Calculations done by Dr. Creuzenet. 
Panel B: Infection of splenocytes (previously exposed to dsbHP::kan mutant) for 12 or 24 
hrs with pure HcpE or DdahB at 25, 75, 125, and 200 ng that was treated with either 
proteinase K (PK) or non-treated lead to the release of pro-inflammatory cytokine IFN-γ. 
ELISA by N. Bronnec and calculations done by Dr. Creuzenet. 
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pro- inflammatory IFN-γ response.  
These results suggest that HcpE is involved in the direct induction of IFN-γ 
production, is capable in inducing a pro-inflammatory response and further modulate the 
splenocytes response to other virulence factors such as LPS as the reduction or absence of 
HcpE results in less IFN-γ is released by splenocytes. 
DISCUSSION 
4.1 The activity of DsbHP and its role in disulfide bond formation  
Dsb proteins are oxidoreductases that are involved in the formation of disulfide 
bonds in the process of protein folding and maturation. Dsbs have been extensively studied 
in E. coli, and two separate pathways of S-S formation have been described. This 
established paradigm does not hold true for H. pylori as only 3 Dsb family members 
(DsbB/I, DsbC, and DsbD) have been thoroughly investigated (Tomb et al, 1997; 
Godlewska et al, 2006). Recently, two separate studies with conflicting results attempted 
to elucidate the function of DsbHP in regards to its ability to form disulfide bonds. Based 
on structural modelling and the ability of DsbHP to act as a reductase on HP0518, a putative 
L,D-transpeptidase, Yoon et al proposed the function of DsbHP to be similar to that of an 
E. coli DsbG. Roszczenko et al proposed the activity of DsbHP to be a DsbA-like oxidase 
based on the ability of DsbHP to refold insulin. Our work on DsbHP has provided additional 
evidence that DsbHP has Dsb-like activity by its ability to refold the surrogate substrate 
lysozyme and restore its activity. Its behavior is similar to that of the E. coli DsbA oxidase 
when expressed in E. coli. Although these  results were unexpected based on our original 
hypothesis that DsbHP would behave like an isomerase due to structural similarities to E. 
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coli DsbG, we provide further support for DsbHP having oxidase catalytic activity similar 
to that of DsbA.  
It was hypothesized that if DsbHP had activity similar to that of DsbA, that an 
abundance of DsbHP within the periplasm would have a protective effect when exposed to 
the reducing agent dithiothreitol. Previous studies have demonstrated that DsbA is 
important during DTT exposure as either E. coli DsbA or DsbC knockout mutants are 
sensitive to DTT (Kamitami et al, 1992; Roszczenko et al, 2012). This phenotype is most 
likely associated with a defect in the proper folding of proteins containing disulfide bonds 
that are translocated into the periplasm. We unexpectedly observed the opposite, where E. 
coli expressing DsbHP or DsbA showed increased toxicity when exposed to dithiothreitol. 
We cannot currently explain the enhanced toxicity of DsbA expression during exposure to 
dithiothreitol. However, the purpose of this study was to demonstrate that DsbHP has Dsb 
catalytic activity, and in particular to distinguish between a DsbA or DsbG-like activity. 
In addition to the experiments in E. coli demonstrating DsbHP activity, we examined 
DsbHP activity in H. pylori as well. To accomplish this we constructed a dsbHP knockout 
mutant. The fact that we were able to isolate clones containing this disrupted gene further 
supports that DsbHP does not contain DsbG-like activity. A dsbG mutant in E. coli is lethal 
and mutants are unable to be recovered unless the medium is supplemented with cysteine 
or another oxidant (Anderson et al, 1997). When the dsbHP mutant was exposed to an 
oxidant in the form of H2O2, an increased sensitivity was observed, clearly demonstrating 
a difference in phenotypes compared to a dsbG mutant in E. coli.  Similar to what was 
observed when expressed in E. coli, the exposure of the dsbHP mutant to a reducing stress 
such as dithiothreitol resulted in sensitivity and lethality. These data, in addition to that 
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obtained from the oxidative stress experiments, suggest that DsbHP may have both DsbA 
and DsbG activities. Thus, this would explain why a DsbA homologue (based on structure) 
has not yet been identified in H. pylori because DsbHP comprises both DsbA and DsbG 
roles within the periplasm.   
DsbHP also appears to have features that E. coli DsbA and DsbG do not possess. 
When HcpE is expressed in E. coli in the absence of DsbHP, insoluble proteins are 
produced. Only when HcpE was co-expressed on the same vector as DsbHP were we able 
to obtain increased amounts of soluble HcpE. This demonstrates that the endogenous Dsb 
proteins were unable to successfully fold and process HcpE even though they contain 
similar activity and homology to DsbHP.   
4.2 HcpE secretion requires DsbHP 
Within the past decade, a family of proteins containing a high percentage of 
cysteine residues has been discovered, named Helicobacter cysteine rich proteins (Hcps). 
HcpE is the largest and most complex member of the Hcp family. HcpE contains the 
greatest number of cysteines (Mittl et al, 2003), and acquisition of an organized array of 
disulfide bonds in the periplasm is anticipated to require proteins of the Disulfide bond 
protein (Dsb) family.  
Previous work from the Creuzenet lab demonstrated that the insoluble unprocessed 
form of HcpE was a substrate for DsbHP. This finding itself was important due to the fact 
that HcpE is the first natural substrate for DsbHP. This was reinforced by the fact that the 
dsbHP knockout mutant was deficient in both HcpE production and secretion, suggesting 
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that HcpE is dependent on DsbHP for proper folding and its secretion into the extracellular 
matrix.  
Due to the fact that Hcp proteins share homologous sequences (Mittl et al, 2003), 
DsbHP could also serve as an important folding factor for the other family members as well.  
This may not be limited to just Hcp family members, as to date DsbHP has been the only 
Dsb protein of H. pylori to demonstrate a DsbA-like activity. Thus, many other H. pylori 
proteins containing cysteine residues could be potential substrates for DsbHP.   
While investigating the relationship between DsbHP and secretion of HcpE, we also 
found that some of HcpE is secreted outside of the cell through OMVs. OMVs have been 
well documented and have been shown to be important delivery mechanisms for many 
enzymes and virulence factors, as well as quorum sensing. OMV production within H. 
pylori has been studied extensively, and implicated in the delivery mechanism for virulence 
factors such as VacA, as well as activation of phagocytes and gastric epithelial cells 
(Mullaney et al, 2009; Parker and Keenan, 2012). Interestingly, previous studies that 
investigated the general proteome of H. pylori OMVs found that other Hcp family 
members, such as HcpC, D, E, and F were contained within the OMVs (Olofsson et al, 
2010). This provides further evidence that HcpE, in addition to other Hcps, are actively 
secreted via OMVs and not just a result of the random packaging of periplasmic contents 
into the OMVs.  
Analysis of clinical strains obtained from biopsies of patients infected with H. 
pylori via anti-HcpE Western blot demonstrated that HcpE is produced and secreted by 
these strains. Taken together, we have provided evidence that HcpE is expressed from H. 
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pylori isolated from infected patients suggesting HcpE is produced in vivo. We have also 
provided novel insight to the fact that HcpE may be differentially expressed during periods 
of infection and disease progression as clinical isolates obtained from patients diagnosed 
with ulcer disease seem to produce more HcpE than the other strains tested. However, this 
needs to be investigated further.   
We demonstrated that the OMVs isolated from our dsbHP knockout mutant were 
almost devoid of HcpE compared to wild-type. Electron microscopy of both dsbHP and 
hcpE knockout mutants provided evidence that our mutants were still capable of producing 
OMVs and that the absence of HcpE was not due to defects in OMV secretion. However, 
we cannot conclude whether the decrease in HcpE in the OMVs of the dsbHP mutant was 
due to a defect in HcpE packaging due to the absence of DsbHP, or just the result of an 
overall decrease in HcpE production inside the cell. We were also not able to determine if 
the disruption of dsbHP resulted in a substantial decrease in other Hcp proteins due to the 
lack of specific antibodies. Nevertheless, this study further demonstrates the importance of 
DsbHP to HcpE production and secretion.  
4.3 Difficulties associated with cloning and expression within H. pylori 
Cloning and the expression of tagged-proteins is difficult to achieve in H. pylori, 
as the bacterium is not hospitable to the uptake of foreign DNA (Ando et al, 2000). This is 
due to the many DNA restriction and modification systems present in H. pylori which help 
prevent transformation by degrading any foreign DNA (Donahue et al, 2000). The DNA 
of H. pylori is methylated, and when DNA is transformed that is either non-methylated or 
the methylation pattern is different from its own, the bacterial restriction modification 
systems become active. To address this challenge, we optimized transformation conditions 
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as well as DNA concentrations. When transforming suicide vectors into H. pylori, as in the 
case with our knockout mutants as well as our complements, the plasmid DNA was either 
treated with H. pylori cell-free extracts (CFE) in the presence of a methyl donor, or was 
transformed without methylation. Incubation with H. pylori CFE would allow the plasmid 
DNA to acquire the same methylation pattern as host genomic DNA, resulting in less 
restriction attack on the plasmid and increase the transformation efficiency in H. pylori 
(Donahue et al, 2000). However, we also tested if transforming non-methylated plasmid 
DNA, but at a much higher concentration, would also increase the transformation 
efficiency in H. pylori. When using non-methylated plasmid DNA, we performed natural 
transformation with 15-20 µg/µl of plasmid. Within this range, clones were usually 
obtained, indicating that when that much foreign DNA is introduced to H. pylori the 
restriction machinery gets overwhelmed, leading to homologous recombination and 
successful transformation. 
E. coli is generally used as a model system for the production and over-expression 
of recombinant H. pylori proteins. For this study, E. coli was used to over-express all 
recombinant proteins as the expression of tagged proteins within H. pylori is difficult due 
to the fact that their endogenous expression levels are too low to purify the quantity of 
proteins needed. Hence, the H. pylori proteins DsbHP and HcpE, as well as E. coli DsbA 
and DsbG were expressed using the pET expression system with a C-terminal hexahistidine 
tag. The pET expression system is a widely used system to mass produce proteins that 
allows for manipulation of the desired protein as well as control of when that expression 
will occur (Studier et al, 1990). The system is highly specific as it uses the T7 promoter 
which only binds T7 RNA polymerase, and is controlled through the lac promoter and 
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operator. The T7 polymerase must be present before the recombinant gene can be 
transcribed, as well as regulated to ensure expression can be manipulated and controlled. 
T7 expression is under the control of an inducible promoter that is activated by IPTG. IPTG 
is a sugar that mimics the lactose metabolite allactose, and when present, displaces the 
repressor from the lac operator allowing T7 polymerase to be expressed. The recombinant 
protein is thus transcribed. This system usually works for most proteins, resulting in the 
production of substantial amounts of the recombinant protein. However, this was not the 
case for HcpE. The expression of HcpE within this system was less efficient, producing 
low amounts of the HcpE protein and always resulting in the production of insoluble 
protein. This made it very difficult to manipulate not only the expression of HcpE, but 
purification needed to be done in denaturing conditions. Thus, we designed a pET 
expression vector which contained both dsbHP and hcpE allowing for simultaneous 
expression of both proteins. Due to the fact that DsbHP is able to interact with and solubilize 
HcpE in vitro, we proposed that expressing both proteins simultaneously would result in a 
larger proportion of soluble HcpE. This proved to be correct as HcpE was observed in the 
soluble protein fraction when expressed in E. coli BL21(DE3)pLys at room temperature. 
Even though this vector still only produced nominal amounts of soluble HcpE, it allowed 
for easier purification as denaturing conditions no longer had to be used.   
The difficulties associated with purifying HcpE was not an isolated incident, as 
difficulties expressing other Hcp family members have also been documented. Expression 
of both HcpC and HcpA in E. coli produces insoluble proteins, thus both proteins need to 
be re-folded before they can be used in experiments (Mittl et al, 2000; Luthy et al, 2004). 
Similarly, before the construction of the co-expression vector, HcpE had to be purified 
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from inclusion bodies in the presence of 6M guanidine-hydrochloride. Considering how 
structurally complex HcpE as well as the other Hcp family members are, it is not surprising 
that they are unable to be folded properly within the periplasm of E. coli. Without their 
proper folding partners/factors to facilitate the formation of the essential disulfide bonds 
between their various cysteine residues, it is not unreasonable that these proteins would 
become insoluble and aggregate into inclusion bodies. However, in the presence of their 
corresponding periplasmic folding factors, as observed within E. coli containing the co-
expression vector, these proteins (HcpE) are able to achieve their proper conformation and 
remain soluble, facilitating their purification from the soluble protein fraction.  
4.4 Implications of HcpE and DsbHP on H. pylori colonization 
Various animal models have been developed to study the colonization as well as 
the pathogenesis of H. pylori within the gastric mucosa. Early studies using larger animals 
such as gnotobiotic piglets, non-human primates and cats were the only animal models that 
provided successful colonization as well as comparable pathology that is associated with 
human infection (reviewed in Masaaki et al, 2005). These models proved to be 
cumbersome due to the difficulties in handling such large animals as well as housing them 
in the large numbers required for study. However, in 1991 Karita and colleagues were the 
first to demonstrate that colonization of H. pylori within mice was possible, as they were 
able to colonize immune-deficient BALB/c mice. This observation led Lee and colleagues 
to screen clinical isolates for their ability to colonize mice. They identified the Sydney 
strain (SS1), and after adaptation in mice were able to sustain colonization in mice over 
long periods of time. They also reported that different mouse strains such as C57BL/6 and 
BALB/c, could be infected to a high degree with the mouse adapted SS1 strain (Lee et al, 
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1997). In our hands, infection and colonization of C57BL/6 mice with the SS1 wild-type 
strain resulted in a bacterial loads ranging from 104-105 cells per gram of stomach tissue 
when calculations were made of numbers of bacteria observed within histological slides. 
Our colonization numbers are lower than that obtained in other studies, as it has been shown 
that mice infected with strain SS1 usually harbor 105-107 CFU per gram of tissue when 
gavaged with as little as 103 CFU (Lee et al, 1997; Ferrero et al, 1997). However, we were 
able to obtain colony counts up to six weeks within the low end of that range with our wild-
type strain. Even though our calculated CFUs were relatively low, we were still able to see 
significant differences among the wild-type, dsbHP and hcpE knockout mutants, 
demonstrating that colonization is reduced when HcpE production is absent. The dsbHP 
knockout mutant was even less capable of maintaining colonization, which may contribute 
to its inability to express any of the Hcp family members. Because Hcp family members 
are homologous in structure (Mittl et al, 2003) and all require disulfide bonds between 
adjacent cysteine residues, DsbHP would probably be required for their maturation and 
secretion similarly to HcpE. We also have to consider that the reduction in colonization of 
both the dsbHP and hcpE knockout mutants may be the result of impaired motility. Motility 
is essential for the successful colonization of H. pylori (Ottemann and Miller, 1997; 
Ottemann and Lowentha, 2002). H. pylori made non-motile by disruption of motB is unable 
to colonize mice as efficiently as the wild-type strain (Nguyan and Saier, 1996). Motility 
allows the bacterium to locate to its preferred region within the gastric mucosa, and enter 
into the neutral mucosal lining to avoid the acidic environment and expulsion from the 
stomach due to peristalsis (Eaton et al, 1992; Ottemann and Miller, 1997; Ottemann and 
Lowentha, 2002). Thus, the differences in colonization observed may be irrelevant to the 
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absence of HcpE production and secretion, and may be due to poor localization into the 
gastric mucosa leading to expulsion from the stomach. However, this needs to be 
investigated further.  
We currently do not understand why  bacterial counts were unobtainable via colony 
counts on agar plates or why colonization numbers of the wild-type strain were low, as all 
preliminary tests with various antibiotics and the homogenization process revealed no signs 
of cellular death in the wild-type SS1 strain.  However, it is important to note that even 
though high colonization rates within mice have be obtained in other studies, H. pylori 
infections within a murine model can be complicated. Previous studies from Marchetti et 
al reported poor colonization of several strains of H. pylori within their SPF conditioned 
BALB/c mice. In addition, H. pylori colonization as well as inflammation and disease 
progression are dependent on both the host and strain of H. pylori (van Doorn et al, 1995; 
Nathalie et al, 1999), indicating that many different factors can have drastic effects on the 
colonization success of H. pylori.  
4.5 Influence of HcpE on murine splenocytes 
Dominant T-helper-1 (Th1) cellular responses are characteristic of H. pylori 
infection, and are thought to play a role in the ability of H. pylori to evade host detection 
and persist over the course of the host’s life time (Mohammadi et al, 1996). Th1 cells are 
the subtype of T helper cells that are responsible for secreting cytokines such as IFN-γ in 
response to pathogens. These are used to communicate to other immune cells to enhance 
phagocytosis as well as iNOS killing. In a mouse infection model using Helicobacter felis, 
it was demonstrated that Th1 cells were responsible for Helicobacter induced disease, 
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whereas Th2 cells had a protective effect due to the fact that they were capable of reducing 
the bacterial load within the gastric mucosa of mice (Mohammadi et al, 1997). It has been 
proposed that the protective effect observed from a Th2-type response in mice may result 
from the induction of local IgA antibody production (Xu-Amano et al, 1993). Infection 
with H. pylori and its ability to promote a Th1 response is thought to counteract this effect 
by blocking the development of a protective (Th2) immune response, and inducing chronic 
inflammation by the production of the pro-inflammatory cytokine IFN-γ.  It is thought that 
the detrimental effect of IFN-γ produced by Th1 cells during H. pylori infection is due to 
the induction and activation of major histocompatibility complex class II molecules 
(MHCII), which may result in the enhanced adherence of H. pylori to the gastric epithelial 
cells as well as induce host cell apoptosis (Fan et al, 1998).  
Our study highly suggests that the secreted protein HcpE produced by H. pylori is 
a virulence factor that may be associated and involved with inducing a polarized Th1 
immune response via the production of IFN-γ. When splenocytes were exposed to 
supernatants obtained from H. pylori grown in liquid medium in the presence of LPS, IFN-
γ was produced. This effect was significantly reduced with supernatants from both dsbHP 
and hcpE knockout mutants, suggesting that HcpE was the antigen responsible for the IFN-
γ modulation to LPS. Purified HcpE was also capable of eliciting an IFN-γ response. IFN-
γ secreted from splenocytes that were incubated with pure HcpE were significantly higher 
than the IFN-γ produced when DdahB was present. Also, the IFN-γ response was negligible 
when HcpE was treated with proteinase K, further supporting that HcpE was the causative 
agent of the IFN-γ response, and demonstrating its role as a pro-inflammatory mediator of 
the polarized Th1 immune response.  
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The observation that HcpE deficient mutants revealed no difference in their 
capacity to induce an IFN-γ response when whole cells were incubated with splenocytes 
indicates that HcpE is not the only IFN-γ inducing component that H. pylori produces. This 
is not unexpected as H. pylori produces several non-secreted virulence factors thought to 
initiate cytokine production that could compensate or mask the differences that would 
normally be seen in response to HcpE (Censini et al, 1996; Dhar et al, 2003; Argent et al, 
2008).  
The Hcp family member HcpA has also been shown to contain immuno-stimulatory 
properties with its ability to induce both IFN-γ and IL-6 secretion (Deml et al, 2005). The 
activation and maturation of immature dendritic cells was observed upon co-culture with 
HcpA, resulting in the induction of pro-inflammatory cytokines TNF-α and IL-6 as well as 
the Th1 polarizing mediators IL-12 and IFN-γ. This was also observed upon co-culture 
with splenocytes from naïve mice, indicating that HcpA is a secreted virulence factor 
capable of inducing pro-inflammatory responses that result in the activation of Th1 
lymphocytes (Deml et al, 2005). Taken together, there is clear evidence that HcpE, as well 
as HcpA, and potentially other Hcp family members, are bacterial components that H. 
pylori employs to trigger the release of pro-inflammatory cytokines to instruct the adaptive 
immune response to initiate a Th1 cellular response. Th1 cellular responses have the 
potential to stimulate and activate the innate immune system causing cellular recruitment 
of phagocytes to the site of infection leading to inflammation and eventually tissue damage. 
However, the mechanisms by which HcpE induces this response, and the balance between 
the Th1/Th2 response needs to be studied in more detail.  
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4.6 Summary and significance 
Through this work, DsbHP was identified as a Dsb protein homologue that is 
involved in the process of disulfide bond formation. Through exposing both E. coli and H. 
pylori to oxidative and reducing stress we demonstrated that DsbHP is functionally similar 
to E. coli DsbA when expressed in E. coli, and may possess both oxidase and isomerase 
properties within H. pylori. This also supports the fact that the paradigm for disulfide bond 
formation established in E. coli is not conserved in H. pylori.  
This work also established that HcpE secreted by H. pylori is largely dependent on 
the presence of functional DsbHP, as HcpE production and secretion was significantly 
reduced in the dsbHP::kan mutant. We demonstrated a potential role for outer membrane 
vesicles in the secretion of HcpE, which could be used as a delivery system to interact with 
host cells. We also established a role for HcpE in the pro-inflammatory Th1 response 
observed during H. pylori infection, demonstrating that HcpE is responsible for inducing 
IFN-γ production during infection of murine splenocytes cells.  
Overall, this work provides novel insights into disulfide bond formation in H. 
pylori, and specifically about the role of DsbHP in H. pylori’s physiology. We have 
enhanced our understanding of interactions between HcpE and DsbHP, as well as laid the 
groundwork to identify a function for HcpE during H. pylori infections. This knowledge 
will contribute to our understanding of H. pylori pathogenicity, and thus provide further 
insight on how we can prevent, or control H. pylori infections in the future. 
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